|
|
|
|
|
 |
|
|
|
AIDS AND INFECTIOUS DISEASES
|
|
Publications 2014
|
DOCUMENT |
I.F. |
CUARTILE |
Cohen, C.; Wohl, D.; Arribas, J. R.; Henry, K.; van Lunzen, J.; Bloch,
M.; Towner, W.; Wilkins, E.; Ebrahimi, R.; Porter, D.; White, K.; Walker, I.; Chuck, S.; de Oertel, S.; Fralich, T. Week 48 results from a randomized clinical trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults. AIDS. 2014; 28(7): 989-997. Artículo. |
5,554 |
D1 |
|
Muñoz, L. C.; Bustos, B. D.; Pinto, P. H.; El Ahmed, H. H.; Ruiz-Villaverde, R.; Ferrer, R. T. Infliximab treatment of psoriasis in supervised infusion centers: case management experience. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 2014; 15(1): S17-S24. Artículo. |
2,725 |
Q1 |
|
Sainz, T.; Díaz, L.; Navarro, M. L.; Rojo, P.; Blázquez, D.; Ramos, J. T.; de José, M. I.; Álvarez-Fuente, M.; Serrano-Villar, S.; Mellado, M. J.; Muñoz-Fernández, M. A. Cardiovascular biomarkers in vertically HIV-infected children without metabolic abnormalities. ATHEROSCLEROSIS. 2014; 233(2): 410-414. Artículo. |
3,994 |
Q1 |
|
Estebánez, M.; Stella-Ascariz, N.; Mingorance, J.; Pérez-Valero, I.; Bernardino, J. I.; Zamora, F. X.; Montes, M. L.; González-García, J. J.; Arribas, J. R. Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study. BMC INFECTIOUS DISEASES. 2014; 14: 379. Artículo. |
2,613 |
Q3 |
|
Pérez-Valero, I.; González-Baeza, A.; Estebánez, M.; Monge, S.; Montes-Ramírez, M. L.; Bayón, C.; Pulido, F.; Bernardino, J. I.; Zamora, F. X.; González-García, J. J.; Lagarde, M.; Hernando, A.; Arnalich, F.; Arribas, J. R. A prospective cohort study of neurocognitive function in aviremic HIV-infected patients treated with 1 or 3 antiretrovirals. CLINICAL INFECTIOUS DISEASES. 2014; 59(11): 1627-1634. Artículo. |
8,886 |
D1 |
|
Tebas, P.; Sension, M.; Arribas, J. R.; Duiculescu, D.; Florence, E.; Hung, C. C.; Wilkin, T.; Vanveggel, S.; Stevens, M.; Deckx, H. Lipid levels and changes in body fat distribution in treatment-naive, HIV-1-infected adults treated with rilpivirine or efavirenz for 96 weeks in the ECHO and THRIVE trials. CLINICAL INFECTIOUS DISEASES. 2014; 59(3): 425-434. Artículo. |
8,886 |
D1 |
Sendagorta, E.; Herranz, P.; Guadalajara, H.; Bernardino, J. I.; Viguer,
J. M.; Beato, M. J.; García-Olmo, D.; Peña, J. M. Prevalence of abnormal anal cytology and high- grade squamous intraepithelial lesions among a cohort of HIV- infected men who have sex with men. DISEASES OF THE COLON & RECTUM. 2014; 57(4): 475-481. Artículo. |
3,749 |
D1 |
|
Górriz, J. L.; Gutiérrez, F.; Trullas, J. C.; Arazo, P.; Arribas, J. R.; Barril, G.; Cervero, M.; Cofan, F.; Domingo, P.; Estrada, V.; Fulladosa, X.; Galindo, M. J.; Gracia, S.; Iribarren, J. A.; Knobel, H.; López-Aldeguer, J.; Lozano, F.; Martínez-Castelao, A.; Martínez, E.; Mazuecos, M. A.; Miralles, C.; Montañés, R.; Negredo, E.; Palacios, R.; Pérez-Elías, M. J.; Portilla, J.; Praga, M.; Quereda, C.; Rivero, A.; Santamaría, J. M.; Sanz, J.; Sanz, J.; Miro, J. M. Executive summary of the recommendations on the evaluation and management of renal disease in human immunodeficiency virusinfected patients. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2014; 32(9): 853-597. Artículo. |
2,172 |
Q3 |
|
Berenguer, J.; Polo, R.; Lozano, F.; Aldeguer, J. L.; Antela, A.; Arribas, J. R.; Asensi, V.; Blanco, J. R.; Clotet, B.; Domingo, P.; Galindo, M. J.; Gatell, J. M.; González-García, J.; Iribarren, J. A.; Locutura, J.; López, J. C.; Mallolas, J.; Martínez, E.; Miralles, C.; Miro, J. M.; Moreno, S.; Palacios, R.; Elías, M.J. P.; Pineda, J. A.; Podzamczer, D.; Portilla, J.; Pulido, F.; Ribera, E.; Riera, M.; Rubio, R.; Santos, J.; Sanz, J.; Tuset, M.; Vida, F.; Rivero, A. Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014). ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2014; 32(7): 447-458. Artículo. |
2,172 |
Q3 |
|
Palter, D. P.; Muñoz-Moreno, J. A.; Rodríguez, D. A.; Villaverde, C. A.; López, A. A.; Andreu, J. B.; Osorio, J. L. C.; Puerto, M. J. G.; Freixa, M.G. I.; Rupérez, J. L.; Bisa, A. L.; París, A. P.; Pérez-Valero, I.; Sogorb, J. P.; Canellas, A. R.; Molina, M. J. T.; Tiraboschi, J. M.; Moragues, E. V.; López, J. R. A.; Sánchez, M. A. G.; de León-Naranjo, F. L.; Chamorro, E. M.; Rodríguez, R. P. Consensus statement on the clinical management of human immunodeficiency virus-associated neurocognitive disorders. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2014; 32(1): 37-47. Artículo. |
2,172 |
Q3 |
Paño Pardo, J. R.; Serrano Villar, S.; Ramos Ramos, J. C.; Pintado, V. Infections caused by carbapenemase-producing enterobacteriaceae: risk
factors, clinical features and prognosis. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2014; 32(Suppl 4): 41-48. Artículo. |
2,172 |
Q3 |
Martínez, E.; González-Cordón, A.; Ferrer, E.; Domingo, P.; Negredo,
E.; Gutiérrez, F.; Portilla, J.; Currán, A.; Podzamczer, D.; Murillas, J.; Bernardino, J. I.; Santos, I.; Cartón, J. A.; Peraire, J.; Pich, J.; Pérez, I.; Gatell, J.M. Early lipid changes with atazanavir/ritonavir or darunavir/ritonavir. HIV MEDICINE. 2014; 15(6): 330-338. Artículo. |
3,988 |
Q1 |
Estebánez, M.; Stella-Ascariz, N.; Mingorance, J.; Pérez-Valero, I.; González-Baeza, A.; Bayón, C.; Lakatos, B.; Borobia, A.; Arnalich, F.; Arribas, J. R. A comparative study of neurocognitively impaired patients receiving protease inhibitor monotherapy or triple-drug antiretroviral
therapy. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2014; 67(4): 419-423. Artículo. |
4,556 |
Q1 |
|
Berenguer, J.; Zamora, F. X.; Carrero, A.; Von Wichmann, M. A.; Crespo, M.; López-Aldeguer, J.; Aldamiz-Echevarría, T.; Montes, M.; Quereda, C.; Téllez, M. J.; Galindo, M. J.; Sanz, J.; Santos, I.; Guardiola, J. M.; Esteban, H.; Bellón, J. M.; González-García, J. Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2014; 66(3): 280-287. Artículo. |
4,556 |
Q1 |
|
Sainz, T.; Álvarez-Fuente, M.; Navarro, M. L.; Díaz, L.; Rojo, P.; Blázquez, D.; de José, M. I.; Ramos, J. T.; Serrano-Villar, S.; Martínez, J.; Medrano, C.; Muñoz-Fernández, M. A.; Mellado, M. J. Subclinical atherosclerosis and markers of immune activation in HIV-infected children and adolescents: the caroVIH Study. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2014; 65(1): 42-49. Artículo. |
4,556 |
Q1 |
|
Montes Ramírez, M. L.; Miro, J. M.; Quereda, C.; Jou, A.; von Wichmann, M. Al.; Berenguer, J.; González-García, J. J.; Hernando, A.; Ortega, E.; Sanz, J.; Arribas, J. R. Incidence of hepatocellular carcinoma in HIVinfected patients with cirrhosis: a prospective study. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2014; 65(1): 82-82. Artículo. |
4,556 |
Q1 |
|
Alessio, R.; Rzany, B.; Eve, L.; Grangier, Y.; Herranz, P.; Olivier-Masveyraud, F.; Vleggaar, D. European expert recommendations on the use of injectable poly-L-lactic acid for facial rejuvenation. JOURNAL OF DRUGS IN DERMATOLOGY. 2014; 13(9): 1057-1066. Artículo. |
1,446 |
Q3 |
|
González-Baeza, A.; Carvajal, F.; Bayón, C.; Pérez-Valero, I.; Estebánez, M.; Bernardino, J. I.; Monge, S.; Lagarde, M.; Hernando, A.; Arnalich, F.; Arribas, J. R. Pattern of neurocognitive function in patients receiving boosted protease inhibitor monotherapy: a detailed neuropsychological study. JOURNAL OF NEUROVIROLOGY. 2014; 20(4): 362-370. Artículo. |
2,595 |
Q3 |
|
Ferrando-Martínez, S.; Lorente, R.; Gurbindo, D.; de José, M. I.; Leal, M.; Muñoz-Fernández, M. A.; Correa-Rocha, R. Low thymic output, peripheral homeostasis deregulation, And hastened regulatory T cells differentiation in children with 22q11.2 deletion syndrome. JOURNAL OF PEDIATRICS. 2014; 164(4): 882-889. Artículo. |
3,79 |
D1 |
|
Bernardino, J. I.; Zamora, F. X.; Valencia, E.; Moreno, V.; Vergas, J.; Téllez, M. J.; Estrada, V.; González-García, J. Efficacy of a dual therapy based on darunavir/ritonavir and etravirine in ART-experienced patients. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2014; 17(4 Suppl 3): 19787. Artículo. |
5,09 |
Q1 |
|
Arribas, J.; Girard, P. M.; Paton, N.; Winston, A.; Marcelin, A. G.; Elbirt, D.; Hill, A.; Hadacek, M. B. Efficacy of PI monotherapy versus triple therapy for 1964 patients in 10 randomised trials. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2014; 17(4 Suppl 3): 197988. Artículo. |
5,09 |
Q1 |
González-Baeza, A.; Pérez-Valero, I.; Carvajal-Molina, F.; Bayón, C.;
Montes-Ramírez, M.; Bernardino, J. I.; Arribas, J. R. Facial emotional
processing deficits in long-term HIV-suppressed patients. JOURNAL
OF THE INTERNATIONAL AIDS SOCIETY. 2014; 17(4 Suppl. 3):
19664. Artículo. |
5,09 |
Q1 |
Arribas, J.; Rizzardini, G.; Arasteh, K.; Zurawski, C.; Dietz, C.; Pontani,
D.; Garner, W.; Nguyen, T. Simplification to Stribild vs continuation of
RTV-boosted DRV with FTC and TDF in virologically suppressed HIV
adults: a STRATEGY-PI subgroup analysis. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2014; 17(4 Suppl3): 19805. Artículo. |
5,09 |
Q1 |
|
Montes, M.; Nelson, M.; Girard, P. M.; Sasadeusz, J.; Horban, A.; Grinsztejn, B.; Zakharova, N.; Rivero, A.; Lathouwers, E.; Janssen, K.; Ouwerkerk-Mahadevan, S.; Witek, J. Telaprevir combination therapy in HCV/HIV co-infected patients (INSIGHT study): sustained virologic response at 12 weeks final analysis. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2014; 17(4 Suppl 3): 19626. Artículo. |
5,09 |
Q1 |
|
Raffi, F.; Babiker, A. G.; Richert, L.; Molina, J. M.; George, E. C.; Antinori, A.; Arribas, J. R.; Grarup, J.; Hudson, F.; Schwimmer, C.; Saillard, J.; Wallet, C.; Jansson, P. O.; Allavena, C.; Van Leeuwen, R.; Delfraissy, J. F.; Vella, S.; Chene, G.; Pozniak, A. Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial. LANCET. 2014; 384(9958): 1942-1951. Artículo. |
45,217 |
D1 |
|
Cahn, P.; Andrade-Villanueva, J.; Arribas, J. R.; Gatell, J. M.; Lama, J. R.; Norton, M.; Patterson, P.; Madero, J. S.; Sued, O.; Figueroa, M. I.; Rolon, M. J. Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviraltherapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, noninferiority GARDEL trial. LANCET INFECTIOUS DISEASES. 2014; 14(7): 572-580. Artículo. |
22,433 |
D1 |
Arribas, J. R.; Pialoux, G.; Gathe, J.; di Perri, G.; Reynes, J.; Tebas, P.;
Nguyen, T.; Ebrahimi, R.; White, K.; Piontkowsky, D. Simplification to
coformulated elvitegravir, cobicistat, emtricitabine, And tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week results of a randomised, open-label, phase 3b, non-inferiority trial. LANCET INFECTIOUS DISEASES. 2014; 14(7): 581-589. Artículo. |
22,433 |
D1 |
|
Alba, M. A.; Velasco, C.; Simeón, C. P.; Fonollosa, V.; Trapiella, L.; Egurbide, M. V.; Sáez, L.; Castillo, M. J.; Callejas, J. L.; Camps, M. T.; Tolosa, C.; Ríos, J. J.; Freire, M.; Vargas, J. A.; Espinosa, G. Early- versus late-onset systemic sclerosis differences in clinical presentation and outcome in 1037 patients. MEDICINE. 2014; 93(2): 73-81. Artículo. |
5,723 |
D1 |
|
Górriz, J. L.; Gutiérrez, F.; Trullas, J. C.; Arazo, P.; Arribas, J. R.; Barril, G.; Cervero, M.; Cofán, F.; Domingo, P.; Estrada, V.; Fulladosa, X.; Galindo, M. J.; Gracia, S.; Iribarren, J. A.; Knobel, H.; López-Aldeguer, J.; Lozano, F.; Martínez-Castelao, A.; Martínez, E.; Mazuecos, M. A.; Miralles, C.; Montañés, R.; Negredo, E.; Palacios, R.; Pérez-Elías, M. J.; Portilla, J.; Praga, M.; Quereda, C.; Rivero, A.; Santamaría, J. M.; Sanz, J.; Sanz, J.; Miro, J. M. Consensus document on the management of renal disease in HIV-infected patients. NEFROLOGÍA. 2014; 34(2): 1-81. Artículo. |
1,223 |
Q3 |
|
Górriz, J. L.; Gutiérrez, F.; Trullas, J. C.; Arazo, P.; Arribas, J. R.; Barril, G.; Cervero, M.; Cofán, F.; Domingo, P.; Estrada, V.; Fulladosa, X.; Galindo, M. J.; Gracia, S.; Iribarren, J. A.; Knobel, H.; López-Aldeguer, J.; Lozano, F.; Martínez-Castelao, A.; Martínez, E.; Mazuecos, M. A.; Miralles, C.; Montañés, R.; Negredo, E.; Palacios, R.; Pérez-Elías, M. J.; Portilla, J.; Praga, M.; Quereda, C.; Rivero, A.; Santamaría, J. M.; Sanz, J.; Sanz, J.; Miro, J. M. Executive summary of the consensus document on the management of renal disease in HIV-infected patients. NEFROLOGÍA. 2014; 34(6): 768-788. Artículo. |
1,223 |
Q3 |
|
Caniglia, E. C.; Cain, L. E.; Justice, A.; Tate, J.; Logan, R.; Sabin, C.; Winston, A.; van Sighem, A.; Miro, J. M.; Podzamczer, D.; Olson, A.; Arribas, J. R.; Moreno, S.; Meyer, L.; del Romero, J.; Dabis, F.; Bucher, H. C.; Wandeler, G.; Vourli, G.; Skoutelis, A.; Lanoy, E.; Gasnault, J.; Costagliola, D.; Hernan, M. A. Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions. NEUROLOGY. 2014; 83(2): 134-141. Artículo. |
8,286 |
D1 |
|
Paton, N. I.; Kityo, C.; Hoppe, A.; Reid, A.; Kambugu, A.; Lugemwa, A.; van Oosterhout, J. J.; Kiconco, M.; Siika, A.; Mwebaze, R.; Abwola, M.; Abongomera, G.; Mweemba, A.; Alima, H.; Atwongyeire, D.; Nyirenda, R.; Boles, J.; Thompson, J.; Tumukunde, D.; Chidziva, E.; Mambule, I.; Arribas, J. R.; Easterbrook, P. J.; Hakim, J.; Walker, A. S.; Mugyenyi, P. Assessment of second-line antiretroviral regimens for HIV therapy in Africa. NEW ENGLAND JOURNAL OF MEDICINE. 2014; 371(3): 234-247. Artículo. |
55,873 |
D1 |
|
Solomon, A.; Tennakoon, S.; Leeansyah, E.; Arribas, J.; Hill, A.; Van Delft, Y.; Moecklinghoff, C.; Lewin, SR. No difference in the rate of change in telomere length or telomerase activity in hiv-infected patients after three years of darunavir/ritonavir with and without nucleoside analogues in the MONET Trial. PLOS ONE. 2014; 9(11): e109718. Artículo. |
3,234 |
Q1 |
|
Palladino, C.; Briz, V.; Bellón, J. M.; Climent, F. J.; de Ory, S. J.; Mellado, M. J.; Navarro, M. L.; Ramos, J. T.; Taveira, N.; de José, M. I.; Muñoz-Fernández, M. A. Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012. PLOS ONE. 2014; 9(5): e96307. Artículo. |
3,234 |
Q1 |
Herranz-Pinto, P.; Sendagorta-Cudós, E.; Bernardino-de la Serna, J. I.;
de Rivera, J. M. P. Anal carcinoma and HIV infection: Is it time for
screening? REVISTA CLÍNICA ESPAÑOLA. 2014; 214(2): 87-93. Artículo. |
1,063 |
Q3 |
Puig, J. G.; Alonso-Vega, G. G.; Blanco, J. J. R. Report of the Editors,
2013. REVISTA CLÍNICA ESPAÑOLA. 2014; 214(1): 38-45. Artículo. |
1,063 |
Q3 |
|
Pozniak, A. L.; Arribas, J. R. FLAMINGO: how much rosier can antiretroviral therapy get? LANCET. 2014; 383(9936): 2191-2193. Material Editorial. |
45,217 |
D1 |
Ramírez, M. L. M.; Vargas, F. X. Z.; González-García, J.; Quereda, C.;
Pérez-Elías, M. J.; de Cea, A.; Barros, C.; Condes, E.; Moreno, J. S.; Santos I.; Torralba, M.; Aldamiz-Echevarría, T.; Moreno, A. Etravirine-based antiretroviral therapy in HIV/hepatitis C virus coinfected advanced
fibrosis patients receiving triple therapy against hepatitis C virus with
telaprevir. AIDS. 2014; 28(16): 2487. Carta. |
5,554 |
D1 |
|
Montes, M. L.; Schapiro, J.; Pérez-Valero, I.; García-Bujalance, S.; Arribas, J. R. Long- term control of HIV replication with dolutegravir and pegylated interferon alpha-2a in an HIV- infected patient with sixtupleclass resistance. AIDS. 2014; 28(6): 932-934. Carta. |
5,554 |
D1 |
Pérez Valero, I.; González-Baeza, A.; Montes Ramírez, M. L. Central
nervous system penetration and effectiveness of darunavir/ritonavir
monotherapy. AIDS REVIEWS. 2014; 16(2): 101-108. Revisión. |
3,787 |
Q2 |
|
Cid, P. M.; Cudós, E. S.; Zamora Vargas, F. X.; Merino, M. J. B.; Pinto, P. H. Pathologically confirmed malignant syphilis using immunohistochemical staining: report of 3 cases and review of the literature. SEXUALLY TRANSMITTED DISEASES. 2014; 41(2): 94-97. Revisión. |
2,842 |
Q2 |
Publications 2009 - 2013
|
YEAR |
NAME |
I.F. |
CUARTILE |
|
2013 |
Stellbrink, H. J.; Reynes, J.; Lazzarin, A.; Voronin, E.; Pulido, F.; Felizarta, F.; Almond, S.; St Clair, M.; Flack, N.; Min, S. (Arribas, J.). Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study. AIDS. 2013; 27(11): 1771-1778. Artículo. |
6,557 |
D1 |
|
2013 |
Estebánez, M.; Stella-Ascariz, N.; Ruiz-Carrascoso, G.; Zamora, F. X.; García-Bujalance, S.; Bernardino, J. I.; Pérez-Valero, I.; Martín-Quirós, A.; Mingorance, J.; Arribas, J. R. Is etravirine and two nucleosides an option for HIV with an isolated K103N mutation? AIDS. 2013; 27(1): 141-144. Artículo. |
6,557 |
D1 |
|
2013 |
Sainz, T.; Serrano-Villar, S.; Díaz, L.; Tome, M. I. G.; Gurbindo, M. D.; de José, M. I.; Mellado, M. J.; Ramos, J. T.; Zamora, J.; Moreno, S.; Muñoz-Fernández, M. A. The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults. AIDS. 2013; 27(9): 1513-1516. Artículo. |
6,557 |
D1 |
|
2013 |
Sainz, T.; Serrano-Villar, S.; Díaz, L.; Tome, M. I. G.; Gurbindo, M. D.; de José, M. I.; Mellado, M. J.; Ramos, J. T.; Zamora, J.; Moreno, S.; Muñoz-Fernández, M. A. The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults. AIDS. 2013; 27(9): 1513-1516. Artículo. |
6,557 |
D1 |
|
2013 |
Moyle, G. J.; Stellbrink, H. J.; Compston, J.; Orkin, C.; Arribas, J.R.; Domingo, P.; Granier, C.; Pearce, H.; Sedani, S.; Gartland, M. 96-Week results of abacavir/lamivudine versus tenofovir/emtricitabine, plus efavirenz, in antiretroviral-naive, HIV-1-infected adults: ASSERT study. ANTIVIRAL THERAPY. 2013; 18(7): 905-913. Artículo. |
3,143 |
Q2 |
|
2013 |
Jarrin, I.; Hernández-Novoa, B.; Alejos, B.; Riera, M.; Navarro,
G.; Bernardino, J. I.; Rivero, M.; del Amo, J.; Moreno, S. Persistence
of novel first-line antiretroviral regimes in a cohort of HIV-positive subjects, CoRIS 2008-2010. ANTIVIRAL THERAPY. 2013; 18(2): 161-170. Artículo. |
3,143 |
Q2 |
|
2013 |
de José, M. I.; de Ory, S. J.; Espiau, M.; Fortuny, C.; Navarro, M. L.; Soler-Palacín, P.; Muñoz-Fernández, M. A. A new tool for the paediatric HIV research: general data from the Cohort of the Spanish Paediatric HIV Network (CoRISpe). BMC INFECTIOUS DISEASES. 2013; 13: 2. Artículo. |
2,561 |
Q3 |
|
2013 |
Hernando, V.; Alejos, B.; Monge, S.; Berenguer, J.; Anta, L.; Vinuesa,
D.; Palacios, R.; Muga, R.; Moreno, S.; Jarrin, I. (García, J. G.; de la Serna, I. B.; López, J. R.; Ramírez, M. L.; Peña, J. M.; Arribas, B.; Castro, J. M.; Vargas, F. J.; Valero, I. P.; Díaz, M.; Blanco, J. R.). All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997-2010. BMC INFECTIOUS DISEASES. 2013; 13: 382. Artículo. |
2,561 |
Q3 |
|
2013 |
Rotger, M; Glass, T. R.; Junier, T.; Lundgren, J.; Neaton, J. D.; Poloni, E. S.; van ‘t Wout, A. B.; Lubomirov, R.; Colombo, S.; Martínez, R.; Rauch, A.; Gunthard, H. F.; Neuhaus, J.; Wentworth, D.; van Manen, D.; Gras, L. A.; Schuitemaker, H.; Albini, L.; Torti, C.; Jacobson, L. P.; Li, X. H.; Kingsley, L. A.; Carli, F.; Guaraldi, G.; Ford, E. S.; Sereti, I.; Hadigan, C.; Martínez, E.; Arnedo, M.; Egana-Gorrono, L.; Gatell, J. M.; Law, M.; Bendall, C.; Petoumenos, K.; Rockstroh, J.; Wasmuth, J. C.; Kabamba, K.; Delforge, M.; de Wit, S.; Berger, F.; Mauss, S.; Sierra, M. D.; Losso, M.; Belloso, W. H.; Leyes, M.; Campins, A.; Mondi, A.; de Luca, A.; Bernardino, I.; Barriuso-Iglesias, M.; Torrecilla-Rodríguez, A.; González-García, J.; Arribas, J. R.; Fanti, I.; Gel, S.; Puig, J.; Negredo, E.; Gutiérrez, M.; Domingo, P.; Fischer, J.; Fatkenheuer, G.; Alonso-Villaverde, C.; Macken, A.; Woo, J.; McGinty, T.; Mallon, P.; Mangili, A.; Skinner, S.; Wanke, C. A.; Reiss, P.; Weber, R.; Bucher, H. C.; Fellay, J.; Telenti, A.; Tarr, P. E. Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons. CLINICAL INFECTIOUS DISEASES. 2013; 57(1): 112-121. Artículo. |
9,416 |
D1 |
|
2013 |
Navarro-San Francisco, C.; Mora-Rillo, M.; Romero-Gómez, M. P.; Moreno-Ramos, F.; Rico-Nieto, A.; Ruiz-Carrascoso, G.; Gómez-Gil, R.; Arribas-López, J. R.; Mingorance, J.; Paño-Pardo, J. R. Bacteraemia due to OXA-48-carbapenemaseproducing Enterobacteriaceae: a major clinical challenge. CLINICAL MICROBIOLOGY AND INFECTION. 2013; 19(2): E72-E79. Artículo. |
5,197 |
D1 |
|
2013 |
Méndez-Lagares, G.; Díaz, L.; Correa-Rocha, R.; Leal, J. A. L.; Ferrando-Martínez, S.; Ruiz-Mateos, E.; Pozo-Balado, M.M.; Gurbindo, M. D.; de José, M. I.; Muñoz-Fernández, M. A.; Leal, M.; Pacheco, Y. M. Specific patterns of CD4-associated immunosenescence in vertically HIV-infected subjects. CLINICAL MICROBIOLOGY AND INFECTION. 2013; 19(6): 558-565. Artículo. |
5,197 |
D1 |
|
2013 |
Maldonado Cid, P.; Sendagorta Cuóos, E.; Noguera Morel, L.; Gómez-Fernández, C.; Beato Merino, M. J.; Hernández-Maraver, D.; Herranz Pinto, P. Acral erythema worsened by intravenous infusions of cyclosporin. DERMATOLOGY ONLINE JOURNAL. 2013; 19(3): 16. Artículo. |
No Indexado |
No Indexado |
|
2013 |
Blasco, A. J.; Llibre, J. M.; Arribas, J. R.; Boix, V.; Clotet, B.; Domingo, P.; González-García, J.; Knobel, H.; López, J. C.; Lozano,
F.; Miró, J. M.; Podzamczer, D.; Santamaría, J. M.; Tuset, M.; Zamora, L.; Lazaro, P.; Gatell, J. M. Analysis of costs and cost-effectiveness of preferred GESIDA/National AIDS Plan regimens for initial antiretroviral therapy in human immunodeficiency virus infected adult patients in 2013. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2013; 31(9): 568-578. Artículo. |
1,881 |
Q3 |
|
2013 |
Domingo, P.; Polo, R.; Lozano, F.; Aldeguer, J. L.; Aguirrebengoa, K.; Estrada, V.; Gutiérrez, F.; Knobel, H.; Llibre, J. M.; Miralles, C.; Miró, J. M.; Rivero, A.; Santos, J.; Tusset, M.; Antela, A.; Asensi, V.; Arribas, J. R.; Blanco, J. R.; Boix, V.; García, F.; Gatell, J. M.; Mallolas, J.; Martínez, E.; Moreno, S.; Palacios, R.; Pérez-Elías, M. J.; Pineda, J. A.; Vidal, F.; Berenguer, J. Executive summary of the Consensus Document of GeSIDA and Spanish Secretariat for the National Plan on AIDS on combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2013). ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2013; 31(9): 604-613. Artículo. |
1,881 |
Q3 |
|
2013 |
Francisco, C. N. S.; del Toro, M. D.; Cobo, J.; de Gea-García, J. H.; Vano-Galván, S.; Moreno-Ramos, F.; Rodríguez-Baño, J.; Paño-Pardo, J. R. Knowledge and perceptions of junior and senior Spanish resident doctors about antibiotic use and resistance: results of a multicenter survey. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLINICA. 2013; 31(4): 199-204. Artículo. |
1,881 |
Q3 |
|
2013 |
Berenguer Berenguer, J.; González-García, J. Pharmacokinetic interactions of telaprevir with other drugs. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2013; 31(Suppl 3): 37-48. Artículo. |
1,881 |
Q3 |
|
2013 |
López-Medrano, F.; Moreno-Ramos, F.; de Cueto, M.; Mora-Rillo, M.; Salavert, M. How to assist clinicians in improving antimicrobial prescribing: tools and interventions provided by stewardship programs. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2013; 31(Suppl 4): 38-44. Artículo. |
1,881 |
Q3 |
|
2013 |
Paño-Pardo, J. R.; Campos, J.; Natera Kindelan, C.; Ramos, A. Initiatives and resources to promote antimicrobial stewardship.: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2013; 31(Suppl 4): 51-55. Artículo. |
1,881 |
Q3 |
|
2013 |
Geretti, A. M.; Arribas, J. R.; Lathouwers, E.; Foster, G. M.; Yakoob, R.; Kinloch, S.; Hill, A.; van Delft, Y.; Moecklinghoff, C. Dynamics of cellular HIV-1 DNA levels over 144 weeks of darunavir/ritonavir monotherapy versus triple therapy in the MONET Trial. HIV CLINICAL TRIALS. 2013; 14(1): 45-50. Artículo. |
2,141 |
Q3 |
|
2013 |
Santos, I. D.; Gómez-Berrocal, A.; Valencia, E.; Asensi, V.; Gijón, P.; Moreno, V.; Vergas, J.; Bernardino, I. Efficacy and tolerability of darunavir/ritonavir in combination with abacavir/lamivudine: an option in selected HIV-infected patients. HIV CLINICAL TRIALS. 2013; 14(5): 254-259. Artículo. |
2,141 |
Q3 |
|
2013 |
Monge, S.; Alejos, B.; Dronda, F.; Del Romero, J.; Iribarren, J.A.; Pulido, F.; Rubio, R.; Miro, J. M.; Gutiérrez, F.; del Amo, J. (González García, J.; de la Serna, I. B.; Sánchez de Rivera, J. M.; López, J. R.; Ramírez, M. L.; Pareja, J. F.; Arribas, B.; Castro, J. M.; Vargas, F. J.; Valero, I. P.) Inequalities in HIV disease management and progression in migrants from Latin America and sub-Saharan Africa living in Spain. HIV MEDICINE. 2013; 14(5): 273-283. Artículo. |
3,454 |
Q2 |
|
2013 |
Elion, R.; Molina, J. M.; López, J. R. A.; Cooper, D.; Maggiolo, F.; Wilkins, E.; Conway, B.; Liu, Y. P.; Margot, N.; Rhee, M.; Chuck, S.L.; Szwarcberg, J. A randomized phase 3 study comparing once-daily elvitegravir with twice-daily raltegravir in treatment-experienced subjects with HIV-1 infection: 96-week results. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2013; 63(4): 494-497. Artículo. |
4,394 |
Q1 |
|
2013 |
Guzmán-Fulgencio, M.; Jiménez, J. L.; García-Álvarez, M.; Bellón, J. M.; Fernández-Rodríguez, A.; Campos, Y.; Rodríguez, C.; González-García, J.; Riera, M.; Viciana, P.; Muñoz-Fernández, M. A.; Resino, S. Mitochondrial haplogroups are associated with clinical pattern of AIDS progression in HIV-infected patients. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2013; 63(2): 178-183. Artículo. |
4,394 |
Q1 |
|
2013 |
Paño-Pardo, J. R.; Ruiz-Carrascoso, G.; Navarro-San Francisco, C.; Gómez-Gil, R.; Mora-Rillo, M.; Romero-Gómez, M. P.; Fernández-Romero, N.; García-Rodríguez, J.; Pérez-Blanco, V.; Moreno-Ramos, F.; Mingorance, J. Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide out-break. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2013; 68(1): 89-96. Artículo. |
5,439 |
D1 |
|
2013 |
Bernardino, J. I.; Pulido, F.; Martínez, E.; Arrizabalaga, J.; Domingo,
P.; Portilla, J.; Ocampo, A.; Muñoz, J.; Torres, R.; Arribas, J. R. Switching to lopinavir/ritonavir with or without abacavir/lamivudine in lipoatrophic patients treated with zidovudine/abacavir/lamivudine. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2013; 68(6): 1373-1381. Artículo. |
5,439 |
D1 |
|
2013 |
Tu, E.; Swenson, L. C.; Land, S.; Pett, S.; Emery, S.; Marks, K.; Kelleher, A. D.; Kaye, S.; Kaiser, R.; Schuelter, E.; Harrigan, R.; (Arribas, J. R.; Castro, J. M.). Results of external quality assessment
for proviral DNA testing of HIV tropism in the Maraviroc Switch
Collaborative study. JOURNAL OF CLINICAL MICROBIOLOGY.
2013; 51(7): 2063-2071. Artículo. |
4,232 |
Q1 |
|
2013 |
Berenguer, J.; Álvarez-Pellicer, J.; Carrero, A.; Von Wichmann, M. A.; López-Aldeguer, J.; Mallolas, J.; Galindo, M. J.; van den Eynde, E.; Téllez, M. J.; Quereda, C.; Tural, C.; Sanz, J.; Barros, C.; Santos, I.; Pulido, F.; Guardiola, J. M.; Ortega, E.; Rubio, R.; Jusdado, J. J.; Montes, M. L.; Gaspar, G.; Barquilla, E.; Bellón, J. M.; González-García, J. Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus. JOURNAL OF HEPATOLOGY. 2013; 58(6): 1104-1112. Artículo. |
10,401 |
D1 |
|
2013 |
Andrade, B. B.; Hullsiek, K. H.; Boulware, D. R.; Rupert, A.; French, M. A.; Ruxrungtham, K.; Montes, M. L.; Price, H.; Barreiro, P.; Audsley, J.; Sher, A.; Lewin, S. R.; Sereti, I. Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis viruses. JOURNAL OF INFECTIOUS DISEASES. 2013; 207(9): 1379-1388. Artículo. |
5,778 |
D1 |
|
2013 |
Raffi, F.; Rachlis, A.; Stellbrink, H. J.; Hardy, W. D.; Torti, C.; Orkin,
C.; Bloch, M.; Podzamczer, D.; Pokrovsky, V.; Pulido, F.; Almond, S.; Margolis, D.; Brennan, C.; Min, S.; (Arribas, J. R.) Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study. LANCET. 2013; 381(9868): 735-743. Artículo. |
39,207 |
D1 |
|
2013 |
Lapausa, M. R.; Pareja, J. F. P.; Asensio, A. N. New tuberculosis
drugs in resistant and multiresistant tuberculosis. MEDICINA
CLÍNICA. 2013; 141(7): 306-313. Artículo. |
1,252 |
Q3 |
|
2013 |
Walmsley, S.L.; Antela, A.; Clumeck, N.; Duiculescu, D.; Eberhard,
A.; Gutiérrez, F.; Hocqueloux, L.; Maggiolo, F.; Sandkovsky, U.; Granier, C.; Pappa, K.; Wynne, B.; Min, S.; Nichols, G.; (Arribas, J. R.) Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection. NEW ENGLAND JOURNAL OF MEDICINE. 2013; 369(19). 1807-1818. Artículo. |
54,42 |
D1 |
|
2013 |
Feito-Rodríguez, M.; de Lucas-Laguna, R.; Gómez-Fernández, C.; Sendagorta-Cudós, E.; Collantes, E.; Beato, M. J.; Boluda, E. R. Cutaneous graft versus host disease in pediatric multivisceral transplantation. PEDIATRIC DERMATOLOGY. 2013; 30(3): 335-341. Artículo. |
1,52 |
Q3 |
|
2013 |
Dapena, M.; Figueras, C.; Noguera-Julián, A.; Fortuny, C.; de José, M. I.; Mellado, M. J.; Gavilán, C.; Falcón-Neyra, M. D.; Navarro, M. L.; de Ory, S. J.; López, C.; Mayol, L.; Méndez, M.; Ciria, L. M.; Coll, M. T.; García, L.; Núñez, E.; Espiau, M.; Soler-Palacín, P. Implementation of occult hepatitis screening in the spanish cohort of HIV-infected pediatric patients. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2013; 32(9): E377-E3779. Artículo. |
3,135 |
D1 |
|
2013 |
Bueno, M.; Calvo, C.; Méndez-Echevarría, A.; de José, M.I.; Santos, M.; Carrasco, J.; Tovizi, M.; Guillén, S.; de Blas, A.; Llorente, M.; Tarrago, A.; Escosa, L.; Cilleruelo, M. J.; Tomatis, C.; Blázquez, D.; Otheo, E.; Mazagatos, D.; García-García, M. L. Oseltamivir treatment for influenza in hospitalized children without underlying diseases. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2013; 32(10): 1066-1069. Artículo. |
3,135 |
D1 |
|
2013 |
Pérez-Valero, I.; González-Baeza, A.; Estebánez, M.; Montes-Ramírez, M. L.; Bayón, C.; Pulido, F.; Bernardino, J. I.; Zamora, F. X.; Monge, S.; Gaya, F.; Lagarde, M.; Rubio, R.; Hernando, A.; Arnalich, F.; Arribas, J. R. Neurocognitive impairment in patients treated with protease inhibitor monotherapy or triple drug antiretroviral therapy. PLOS ONE. 2013; 8(7): e69493. Artículo. |
3,534 |
Q1 |
|
2013 |
Sendagorta Cudós, E.; Romero Gómez, M. P.; Hernández Novoa, B.; Mayor, A.; Bernardino de la Serna, J. I.; Estebánez Muñoz, M.; Viguer Moreno, J. M.; Beato Merino, M. J.; Herranz Pinto, P. Human papillomavirus mRNA testing for the detection of anal high-grade squamous intraepithelial lesions in HIV-positive men who have sex with men. SEXUAL HEALTH. 2013; 10(6): 573-574. Artículo. |
1,576 |
Q3 |
|
2013 |
Arribas, J. R. Initial antiretroviral therapy: the dilemmas ahead. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2013; 31(2): 68-70. Material Editorial. |
1,881 |
Q3 |
|
2013 |
Pozniak, A. L.; Arribas, J. R. A benchmark for management of drug resistant HIV. LANCET INFECTIOUS DISEASES. 2013; 13(7): 561-562. Material Editorial. |
19,446 |
D1 |
|
2013 |
Arribas, J.; Pulido, F.; Hill, A.; van Delft, Y.; Moecklinghoff, C.
Predictors of long-term HIV RNA suppression on darunavir/ritonavir
monotherapy in the MONET trial. INTERNATIONAL JOURNAL
OF STD & AIDS. 2013; 24(8): 679-681. Carta. |
1,037 |
Q4 |
|
2013 |
Mora-Rillo, M.; Martín-Suñé, N.; Romero-Gómez, M. R.; Fernández-
Capitán, M. C. Polymicrobial endocarditis: chronic Q fever and enterococcus faecalis coinfection. REVISTA CLÍNICA ESPAÑOLA. 2013; 213(3): 172-173. Carta. |
1,314 |
Q3 |
|
2013 |
Lete, A. L.; Suñé, N. M.; Pellicer, J. A.; Blanco, J. J. R. Aeromonas
diarrhea and Behcet’s disease: more than a mere association. RHEUMATOLOGY INTERNATIONAL. 2013; 33(2): 543-544. Carta. |
1,627 |
Q3 |
|
2013 |
Arribas, J. R.; Doroana, M.; Turner, D.; Vandekerckhove, L.; Streinu-Cercel, A. Boosted protease inhibitor monotherapy in HIV-infected adults: outputs from a pan-european expert panel meeting. AIDS RESEARCH AND THERAPY. 2013; 10: 3. Revisión. |
1,841 |
Q4 |
|
2013 |
Soto-Abánades, C. I.; Alcolea-Batres, S.; Ríos-Blanco, J. J. Pulmonary hypertension in patients infected with human immunodeficiency virus: current situation. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2013; 31(7): 461-470. Revisión. |
1,881 |
Q3 |
|
2012 |
Sobrino-Vegas, P.; Rodríguez-Urrego, J.; Berenguer, J.; Caro-Murillo, A. M.; Blanco, J. R.; Viciana, P.; Moreno, S.; Bernardino, I.; del Amo, J. Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care. ANTIVIRAL THERAPY. 2012; 17(1): 1-8. Article. |
3,073 |
Q2 |
|
2012 |
García-González, C.; García-Bujalance, S.; Ruiz-Carrascoso,
G.; Arribas, J. R.; González-García, J.; Bernardino, J. I.; Pascual-
Pareja, J. F.; Martínez-Prats, L.; Delgado, R.; Mingorance, J. Detection and quantifi cation of the K103N mutation in HIV reverse transcriptase by pyrosequencing. DIAGNOSTIC
MICROBIOLOGY AND INFECTIOUS DISEASE. 2012; 72(1): 90-96. Article. |
2,26 |
Q3 |
|
2012 |
Blasco, A. J.; Arribas, J. R.; Boix, V.; Clotet, B.; Domingo, P.;
González-García, J.; Knobel, H.; López, J. C.; Llibre, J. M.; Lozano, F.; Miró, J. M.; Podzamczer, D.; Santamaría, J. M.; Tuset, M.; Zamora, L.; Lázaro, P.; Gatell, J. M. Costs and costefficacy analysis of the preferred treatments by GESIDA/National plan for AIDS for the initial antiretroviral therapy in adult human Immunodefi ciency virus (HIV) infected patients in 2012. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2012; 30(6): 283-293. Article. |
1,478 |
Q4 |
|
2012 |
Berenguer, J.; Pedrol, P. D.; Polo, R.; Aguirrebengoa, K.; Estrada, V.; Rodero, F. G.; Knobel, H.; Llibre, J. M.; Miralles, C.; Miró, J. M.; Rivero, A.; Santos, J.; Tuset, M.; Antela, A.; Asensi, V.; Arribas, J. R.; Blanco, J. R.; Boix, V.; Martínez, E.; García, F.; Gatell, J. M.; Mallolas, J.; Moreno, S.; Palacios, R.;
Elías, M. J. P.; Pineda, J. A.; Vidal, F.; Aldeguer, J. L. E xecutive
summary. Consensus document of GESIDA and SPNS (Spanish Secretariat for the National Plan on AIDS) regarding combined antiretroviral treatment in adults infected by the human immunodefi ciency virus (January 2012). ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2012; 30(6): 315-324. Article. |
1,478 |
Q4 |
|
2012 |
Monge, S.; del Romero, J.; Rodríguez, C.; de Mendoza, C.; de
Górgolas, M.; Cosin, J.; Dronda, F.; Pérez-Cecilia, E.; Pena, J. M.; Santos, I.; Rubio, R.; del Amo, J. Socio-demographic factors associated with the progression of HIV infection and the impact of HAART in a seroconverter cohort in Madrid (1986-2009). ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA
CLÍNICA. 2012; 30(3): 117-123. Article. |
1,478 |
Q4 |
|
2012 |
Pérez-Molina, J. A.; Rillo, M. M.; Suárez-Lozano, I.; Casado-Osorio, J. L.; Cobo, R. T.; González, P. R.; Clotet, E. P.;
Hernando-Jerez, A.; Domingo, P.; Díaz, E. B.; Esteban, H.;
González-García, J. Response to combined antiretroviral
therapy according to gender and origin in a cohort of naive
HIV-infected patients: GESIDA-5808 Study. HIV CLINICAL
TRIALS. 2012; 13(3): 131-141. Article. |
2,304 |
Q2 |
|
2012 |
Arribas, J. R.; Clumeck, N.; Nelson, M.; Hill, A.; van Delft, Y.; Moecklinghoff, C. The MONET trial: week 144 analysis of the effi cacy of Darunavir/Ritonavir (DRV/r) monotherapy versus DRV/r plus two nucleoside reverse transcriptase inhibitors, for patients with viral load < 50 HIV-1 RNA copies/mL at baseline. HIV MEDICINE. 2012; 13(7): 398-405. Article. |
3,155 |
Q2 |
|
2012 |
Arribas, J.; Bernardino, J.; Hill, A.; Sawyer, W.; van Delft, Y.;
Moecklinghoff, C. Effects of switching to PI monotherapy on measures of lipoatrophy: meta-analysis of six randomized HIV clinical trials. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2012; 15(6): 18281. Article. |
3,936 |
Q1 |
|
2012 |
Bernardino, J.; Merino, J.; Serrano, L.; Estebánez, M.; Montes,
M.; Zamora, F.; Pérez-Valero, I.; González-García, J.; Arribas, J. Longitudinal comparison of infl ammatory, coagulation and metabolic biomarkers in patients who start ART versus patients who remain ART-naive. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2012; 15(6): 18284. Article. |
3,936 |
Q1 |
|
2012 |
Arribas, J.; Pulido, F.; Hill, A.; van Delft, Y.; Moecklinghoff, C.
Predictors of long-term HIV RNA suppression on Darunavir/
Ritonavir monotherapy in the MONET trial. JOURNAL OF THE
INTERNATIONAL AIDS SOCIETY. 2012; 15(6): 18354. Article. |
3,936. |
Q1 |
|
2012 |
Valero, I. P.; Letendre, S.; Ellis, R.; Deutsch, R.; Franklin, D.;
Clifford, D.; Heaton, R.; McCutchan, J.; McArthur, J.; Morgello,
S.; Gelman, B.; Collier, A.; Grant, I. Prevalence and risk factors for HIV CSF viral escape: results from the CHARTER and HNRP cohorts. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2012; 15(Suppl. 4): 18189. Article. |
3,936 |
Q1 |
|
2012 |
Pérez-Valero, I.; González-Baeza, A.; Estebánez, M.; Montes,
M.; Bayón, C.; Pulido, F.; Cambron, I.; Bernardino, J.; Zamora,
F.; Monge, S.; Gaya, F.; Lagarde, M.; Rubio, R.; Hernando,
A.; González-García, J.; Arnalich, F.; Arribas, J. Prolonged
treatment with boosted protease inhibitor monotherapy is not associated with a higher rate of neurocognitive impairment than triple drug ART. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2012; 15(6): 18179. Article. |
3,936 |
Q1 |
|
2012 |
van Lunzen, J.; Maggiolo, F.; Arribas, J. R.; Rakhmanova, A.; Yeni, P.; Young, B.; Rockstroh, J. K.; Almond, S.; Song, I.; Brothers, C.; Min, S. Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a doseranging, randomised, phase 2b trial. LANCET INFECTIOUS DISEASES. 2012; 12(2): 111-118. Article. |
19,966 |
D1 |
|
2012 |
Pulido, F.; Arribas, J.; Hill, A.; Moecklinghoff, C. No Evidence
for evolution of protease inhibitor resistance from standard genotyping, after three years of treatment with Darunavir/Ritonavir, with or without nucleoside analogues. AIDS RESEARCH AND HUMAN RETROVIRUSES. 2012; 28(10): 1167-1169. Letter. |
2,705 |
Q2 |
|
2012 |
Pérez-Valero, I.; Cysique, L.; Letendre, S.; Heaton, R. Comments
to Garvey et al: “Low rates of neurocognitive impairment are observed in Neuro-Asymptomatic HIV-infected subjects on effective antiretroviral therapy”. HIV CLINICAL TRIALS. 2012; 13(5): 296-298. Letter. |
2,304 |
Q2 |
|
2012 |
Arribas, J.; Hill, A.; Xi, N.; van Delft, Y.; Moecklinghoff, C. Interleukin-6 and C-reactive protein levels after 3 years of
treatment with Darunavir/Ritonavir monotherapy or Darunavir/
Ritonavir plus two nucleoside reverse transcriptase inhibitors in the MONET trial. JOURNAL OF ANTIMICROBIAL
CHEMOTHERAPY. 2012; 67(7): 1804-1806. Letter. |
5,338 |
D1 |
|
2012 |
Estebánez, M.; Arribas, J. R. Protease inhibitor monotherapy:
what is its role? CURRENT HIV/AIDS REPORTS. 2012; 9(2):
179-185. Review. |
No tiene |
No tiene |
|
2012 |
Estebánez-Muñoz, M.; Stella, N.; Bernardino, J. I. HIV infection
and chronic infl ammation: Is the bacterial translocation the underlying cause? MEDICINA CLÍNICA. 2012; 138(15): 673-677. Review. |
1,399 |
Q2 |
|
2012 |
Baker, J. V.; Neuhaus, J.; Duprez, D.; Freiberg, M.; Bernardino,
J. I.; Badley, A. D.; Nixon, D. E.; Lundgren, J. D.; Tracy, R.
P.; Neaton, J. D. HIV Replication, infl ammation, and the effect
of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2012; 60(2): 128-134. Article. |
4,653 |
Q1 |
|
2012 |
Ramírez, M. L. M.; Pascual-Pareja, J. F.; Sánchez-Conde, M.;
de la Serna, J. I. B.; Vargas, F. X. Z.; Miralles, P.; Castro, J. M.;
Ramírez, M.; Gutiérrez, I.; González-García, J.; Berenguer, J.; López, J. R. A. Transient elastography to rule out esophageal varices and portal hypertensive gastropathy in HIV-infected individuals with liver cirrhosis. AIDS. 2012; 26(14): 1807-1812. Article. |
6,407 |
D1 |
|
2012 |
Berenguer, J.; Rodríguez, E.; Miralles, P.; Von Wichmann, M.
A.; López-Aldeguer, J.; Mallolas, J.; Galindo, MJ.; van den Eynde, E.; Téllez, M. J.; Quereda, C.; Jou, A.; Sanz, J.; Barros, C.; Santos, I.; Pulido, F.; Guardiola, J. M.; Ortega, E.; Rubio, R.; Jusdado, J. J.; Montes, M. L.; Gaspar, G.; Esteban, H.; Bellón, J. M.; González-García, J. Sustained virological response to Interferon Plus Ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virus. CLINICAL INFECTIOUS DISEASES. 2012; 55(5): 728-736. Article. |
9,374 |
D1 |
|
2012 |
García-Jurado, L.; Oyáguez, I.; Casado, M. A.; Tural, C.; González-
García, J.; Ortega, E.; Pineda, J. A. Evaluation of the costs of transient elastography (FibroScan (R)) in the diagnosis of liver fi brosis in HIV patients with hepatitis C virus. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2012; 30(6): 294-299. Article. |
1,478 |
Q4 |
|
2012 |
Hernando, V.; Pérez-Cachafeiro, S.; Lewden, C.; González, J.;
Segura, F.; Oteo, J. A.; Rubios, R.; Dalmáu, D.; Moreno, S.; del
Amo, J. All-cause and liver-related mortality in HIV positive subjects compared to the general population: Differences by HCV co-infection. JOURNAL OF HEPATOLOGY. 2012; 57(4): 743-751. Article. |
9,858 |
D1 |
|
2012 |
Moreno, A.; Quereda, C.; Montes, M.; Pérez-Elías, M. J.; Casado, J. L.; Rodríguez-Sagrado, M. A.; Mateos, M. L.; Dronda, F.; Barcena, R.; del Campo, S.; Moreno, S. Safe coadministration of Raltegravir-based HAART in HIV-Infected patients with HCV-Cirrhosis receiving triple therapy with telaprevir or Boceprevir. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2012; 61(3): e47-e49. Letter. |
4,653 |
Q1 |
|
2012 |
Guillén, S.; Prieto, L.; de Ory, S. J.; González-Granado, I.; González-Tome, M. I.; Mellado, M. J.; de José, M.; Navarro,
M. L.; Beceiro, J.; Roa, M. A.; Muñoz, M. A.; Ramos, J. T. New
diagnosis of HIV infection in children. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2012; 30(3): 131-136. Article. |
1,478 |
Q4 |
|
2012 |
Díaz, L.; Méndez-Lagares, G.; Correa-Rocha, R.; Pacheco, Y.
M.; Ferrando-Martínez, S.; Ruiz-Mateos, E.; del Pozo-Balado,
M. D.; León, J. A.; Gurbindo, M. D.; de José, M. I.; Leal, M.;
Muñoz-Fernández, M. A. Detectable viral load aggravates immunosenescence features of CD8 T-Cell subsets in vertically
HIV-infected children. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2012; 60(5): 447-454.
Article. |
4,653 |
Q1 |
|
2012 |
Dapena, M.; Jiménez, B.; Noguera-Julián, A.; Soler-Palacín,
P.; Fortuny, C.; Lahoz, R.; Aracil, F. J.; Figueras, C.; de José, M.
I. Metabolic disorders in vertically HIV-infected children: future
adults at risk for cardiovascular disease. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM. 2012; 25(05 jun): 529-535. Article. |
0,747 |
Q4 |
|
2012 |
Briz, V.; García, D.; Méndez-Lagares, G.; Ruiz-Mateos, E.; de
Mulder, M.; Moreno-Pérez, D.; Navarro, M. L.; León-Leal, J.
A.; de José, M. I.; Ramos, J.; Mellado, M. J.; González-Tomé,
M. I.; Leal, M.; Muñoz-Fernández, M. A. High prevalence of
X4/DM-Tropic variants in children and adolescents infected
with HIV-1 by vertical transmission. PEDIATRIC INFECTIOUS
DISEASE JOURNAL. 2012; 31(10): 1048-1052. Article. |
3,569 |
D1 |
|
2012 |
Prieto, L. M.; González-Tomé, M. I.; Muñoz, E.; Fernández Ibieta, M.; Soto, B.; del Rosal, T.; Cuadrado, I.; Navarro, M.L.; Roa, M. A.; Beceiro, J.; de José, M. I.; Santos, M. J.; Lora, D.; Ramos, J. T. Low rates of mother-to-child transmission of HIV-1 and risk factors for infection in Spain: 2000-2007. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2012; 31(10): 1053-1058. Article. |
3,569 |
D1 |
|
2012 |
Briz, V.; León-Leal, J. A.; Palladino, C.; Moreno-Pérez, D.; de
Ory, S. J.; de José, M. I.; González-Tomé, M. I.; Martín, C. G.;
Pocheville, I.; Ramos, J. T.; Leal, M.; Muñoz-Fernández, M. A.
Potent and sustained antiviral response of raltegravir-based highly active antiretroviral therapy in HIV type 1-infected children and adolescents. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2012; 31(3): 273-277. Article. |
3,569 |
D1 |
|
2012 |
de Mulder, M.; Yebra, G.; Navas, A.; Martin, L.; de José, M. I.;
Navarro, M. L.; de Ory, S. J.; González-Granado, I.; Mellado,
M. J.; Ramos, J. T.; Holguin, A. Trends in drug resistance prevalence
in HIV-1-infected children in Madrid: 1993 to 2010 Analysis. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2012; 31(11): e213-e221. Article. |
3,569 |
D1 |
|
2012 |
Vecino, R.; Santiago, B.; Baquero-Artigao, F.; López, G. L.; García, C.; Muñoz, G.; Prieto, G.; Martínez, A.; de José, M.I.; Mejias, A. Tuberculosis in pediatric solid organ and hematopoietic stem cell transplant recipients. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2012; 31(7): 774-777. Article. |
3,569 |
D1 |
|
2012 |
de Mulder, M.; Yebra, G.; Navas, A.; de José, M. I.; Gurbindo,
M. D.; González-Tomé, M. I.; Mellado, M. J.; Saavedra-Lozano, J.; Muñoz-Fernández, M. A.; de Ory, S. J.; Ramos, J. T.; Holguin, A. High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain. PLOS ONE. 2012; 7(12): e52155. Article. |
3,73 |
Q1 |
|
2012 |
Paño-Pardo, J. R.; Rodríguez-Bano, J.; Martínez-Sánchez, N.;
Viasus, D.; Farinas, M. C.; Leyes, M.; López-Medrano, F.; Pachón,
J.; Torre-Cisneros, J.; Oteo, J. A.; Pumarola, T.; García-Gasalla, M.; Ortega, L.; Segura, F.; Carratala, J. Prognosis of 2009 A(H1N1) infl uenza in hospitalized pregnant women in a context of early diagnosis and antiviral therapy. ANTIVIRAL THERAPY. 2012; 17(4): 719-728. Article. |
3,073 |
Q2 |
|
2012 |
Viasus, D.; Cordero, E.; Rodríguez-Bano, J.; Oteo, J. A.; Fernández-Navarro, A.; Ortega, L.; Gracia-Ahufi nger, I.; Farinas,
M. C.; García-Almodóvar, E.; Payeras, A.; Paño-Pardo, J. R.;
Muñez-Rubio, E.; Carratala, J. Changes in epidemiology, clinical
features and severity of infl uenza A (H1N1) 2009 pneumonia
in the fi rst post-pandemic infl uenza season. CLINICAL MICROBIOLOGY AND INFECTION. 2012; 18(3): E55-E62. Article. |
4,578 |
Q1 |
|
2012 |
Romero-Gómez, M. P.; Quiles-Melero, I.; Navarro, C.; Paño-
Pardo, J. R.; Gómez-Gil, R.; Mingorance, J. Evaluation of the
BinaxNOW PBP2a assay for the direct detection of methicillin
resistance in staphylococcus aureus from positive blood culture bottles. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS
DISEASE. 2012; 72(3): 282-284. Article. |
2,26 |
Q3 |
|
2012 |
Casado-Verrier, B.; Gómez-Fernández, C.; Paño-Pardo, J.
R.; Gómez-Gil, R.; Mingorance-Cruz, J.; de Celada, R. M. A.;
Herranz-Pinto, P. Community-acquired methicillin resistant
staphylococcus aureus skin and soft tissue infections in Madrid: prevalence study. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2012; 30(6): 300-306. Article. |
1,478 |
Q4 |
|
2012 |
Fernández-Ruiz, M.; Estebánez-Muñoz, M.; López-Medrano,
F.; Aguado, J. M. Iliopsoas abscess: therapeutic approach
and outcome in a series of 35 patients. ENFERMEDADES
INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2012; 30(6): 307-311. Article. |
1,478 |
Q4 |
|
2012 |
Cordero, E.; Aydillo, T.; Farinas, M. C.; Paño-Pardo, J. R.; Pachón,
J.; Viasus, D.; Riera, M.; López-Medrano, F.; Payeras, A.; Moreno, A.; Rodríguez-Bano, J.; Oteo, J. A.; Martínez-Montauti, J.; Torre-Cisneros, J.; Segura, F.; Carratala, J. Immunosuppressed
patients with pandemic infl uenza A 2009 (H1N1) virus infection. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2012; 31(4): 547-556. Article. |
3,024 |
Q2 |
|
2012 |
Romero-Gómez, M. P.; Gómez-Gil, R.; Paño-Pardo, J. R.; Mingorance, J. Identifi cation and susceptibility testing of microorganism by direct inoculation from positive blood culture
bottles by combining MALDI-TOF and Vitek-2 Compact is rapid and effective. JOURNAL OF INFECTION. 2012; 65(6): 513-520. Article. |
4,073 |
Q1 |
|
|
Paño-Pardo, J. R.; Viasus, D.; Pachón, J.; Campins, A.; López-
Medrano, F.; Villoslada, A.; Gutiérrez-Cuadra, M.; Pumarola, T.; del Toro, M. D.; Oteo, J. A.; Martínez-Montauti, J.; Gutiérrez-Aroca, J.; Segura, F.; Carratala, J. Pandemic 2009 A(H1N1) infection requiring hospitalization of elderly spanish adults. JOURNAL OF THE AMERICAN GERIATRICS
SOCIETY. 2012; 60(4): 740-744. Article. |
3,978 |
Q1 |
|
2012 |
García-Bujalance, S.; Navarro-San Francisco, C.; Rubio, J.
M.; Arribas, J. R.; Gutiérrez, A. Imported Plasmodium Falciparum
Malaria in HIV-infected patients: a report of two cases. MALARIA JOURNAL. 2012; 11: 136. Article. |
3,4 |
D1 |
|
2012 |
Lapausa, M. R.; Pareja, J. F. P.; Pérez, M. A.; Pérez, J. L. V.;
Asensio, A. N. Outcome and treatment among patients with multidrug-resistant tuberculosis. MEDICINA CLÍNICA. 2012;
138(1): 643-649. Article. |
1,399 |
Q2 |
|
2012 |
Ramírez-Olivencia, G.; Herrero, M. D.; Subirats, M.; de Juanes,
J. R.; Peña, J. M.; Puente, S. Imported Malaria in adults. Clinical, epidemiological and analytical features. REVISTA CLÍNICA ESPAÑOLA. 2012; 212(1): 1-9. Article. |
No tiene |
No tiene |
|
2012 |
Rodríguez-Baño, J.; Paño-Pardo, J. R.; Álvarez-Rocha, L.; Asensio, A.; Calbo, E.; Cercenado, E.; Cisneros, J. M.; Cobo, J.; Delgado, O.; Garnacho-Montero, J.; Grau, S.; Horcajada, J. P.; Hornero, A.; Murillas-Angoiti, J.; Oliver, A.; Padilla, B.; Pasquau, J.; Pujol, M.; Ruiz-Garbajosa, P.; San Juan, R.; Sierra, R. Programs for optimizing the use of antibiotics (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2012; 30(1): 22-23. Editorial Material. |
1,478 |
Q4 |
|
2012 |
Suárez-García, I.; Paño-Pardo, J. R.; Noguerado, A. Multidrug-
resistant tuberculous spondylitis. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2012; 30(7): 424-245. Letter. |
1,478 |
Q4 |
|
2012 |
Sendagorta, E.; Vidaurrazaga, C.; Mulekyo, R. Hyperpigmented
plaque on the foot of a kenyan patient. ACTAS DERMOSIFILIOGRÁFICAS. 2012; 103(7): 633-634. Article. |
N/A |
N/A |
|
2012 |
Ramírez, P.; Feito, M.; Sendagorta, E.; González-Beato, M.; de Lucas, R. Childhood actinic lichen planus: Successful treatment with antimalarials. AUSTRALASIAN JOURNAL OF DERMATOLOGY. 2012; 53(1): e10-e13. Article. |
0,965. |
Q3 |
|
2012 |
Ramírez-Olivencia, G.; Herrero, M. D.; Subirats, M.; de Juanes,
J. R.; Peña, J. M.; Puente, S. Imported Malaria and HIV infection in Madrid. Clinical and epidemiological features. REVISTA CLÍNICA ESPAÑOLA. 2012; 212(1): 10-17. Article. |
No tiene |
No tiene |
|
2012 |
Puig, J. G.; Alonso-Vega, G. G.; Blanco, J. J. R. Report of the
editors, 2011. REVISTA CLÍNICA ESPAÑOLA. 2012; 212(1): 31-39. Article. |
No tiene |
No tiene |
|
2012 |
Blanco, J. J. R.; Suñe, N. M.; Pellicer, J. A.; Hernandez, F.J. B. Anti-neutrophil cytoplasmic antibodies: beyond vasculitis. MEDICINA CLÍNICA. 2012; 139(3): 137-138. Letter. |
1,399 |
Q2 |
|
2012 |
Martín-Suñe, N.; Ríos-Blanco, J. J. Pulmonary affectation
of Vasculitis. ARCHIVOS DE BRONCONEUMOLOGÍA. 2012;
48(11): 410-418. Review. |
1,372 |
Q4 |
|
2012 |
Estebánez-Muñoz, M.; Soto-Abanades, C. I.; Ríos-Blanco, J.J.; Arribas, J. R. Updating our understanding of pulmonary disease associated with HIV infection. ARCHIVOS DE BRONCONEUMOLOGÍA. 2012; 48(4); 126-132. Review. |
1.372 |
Q4 |
|
2012 |
Simeón-Aznar, C. P.; Fonollosa-Pla, V.; Tolosa-Vilella, C.; Espinosa-Garriga, G.; Ramos-Casals, M.; Campillo-Grau, M.;
García-Hernandez, F.; Castillo-Palma, M. J.; Saáchez-Román,
J.; Callejas-Rubio, J. L.; Ortego-Centeno, N.; Egurbide-Arberas,
M. V.; Trapiellla-Martínez, L.; Gallego-Villalobos, M.; Sáez-Comet, L.; Velilla-Marco, J.; Camps-García, M. T.; de ramon-Garrido, E.; Marcos, E. M. E.; Pallares-Ferreres, L.; Hidalgo-Tenorio, C.; Sabio-Sánchez, J. M.; Gómez-de la Torre, R.; Salvador-Cervello, G.; Ríos-Blanco, J. J.; Gil-Aguado, A.; Vilardell-Tarres, M. Registry of the spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2012; 41(6): 789-800. Review. |
3,806 |
Q2 |
|
2011 |
Llibre, J. M.; Arribas, J. R.; Domingo, P.; Gatell, J. M.; Lozano, F.; Santos, J. R.; Rivero, A.; Moreno, S.; Clotet, B. Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy. AIDS. 2011; 25(14): 1683-1690. Article. |
6,245 |
D1 |
|
2011 |
Pulido, F.; Arribas, J. R.; Hill, A.; Van Delft, Y.; Moecklinghoff, C. Analysis of drug resistance during HIV RNA viraemia in the MONET trial of darunavir/ritonavir monotherapy. ANTIVIRAL THERAPY. 2011; 16(1): 59-65. Article. |
3,161 |
Q2 |
|
2011 |
McKinnon, J. E.; Delgado, R.; Pulido, F.; Shao, W.; Arribas, J. R.; Mellors,
J. W. Single genome sequencing of HIV-1 gag and protease resistance mutations at virologic failure during the OK04 trial of simplified versus standard maintenance therapy. ANTIVIRAL THERAPY. 2011; 16(5): 725-732. Article. |
3,161 |
Q2 |
|
2011 |
Lejeune, M.; Miro, J. M.; De Lazzari, E.; García, F.; Claramonte, X.;
Martínez, E.; Ribera, E.; Arrizabalaga, J.; Arribas, J. R.; Domingo,
P.; Ferrer, E.; Plana, M.; Valls, M. E.; Podzamczer, D.; Pumarola, T.;
Jacquet, A.; Mallolas, J.; Gatell, J. M.; Gallart, T. Restoration of T
Cell Responses to Toxoplasma gondii after Successful Combined
Antiretroviral Therapy in Patients with AIDS with Previous Toxoplasmic Encephalitis. CLINICAL INFECTIOUS DISEASES. 2011; 52(5): 662-670. Article. |
9,154 |
D1 |
|
2011 |
Pérez-Valero, I.; Arribas, J. R. Protease inhibitor monotherapy. CURRENT OPINION IN INFECTIOUS DISEASES. 2011; 24(1): 7-11. Review. |
4,93 |
Q1 |
|
2011 |
Pérez-Molina, J. A.; Suárez-Lozano, I.; del Arco, A.; Teira, R.; Bachiller,
P.; Pedrol, E.; Martínez-Alfaro, E.; Domingo, P.; Marino, A.; Ribera, E.; Antela, A.; de Otero, J.; Navarro, V.; González-García, J. Late Initiation of HAART Among HIV-Infected Patients in Spain Is Frequent and Related to a Higher Rate of Virological Failure but not to Immigrant Status. HIV CLINICAL TRIALS. 2011; 12(1): 1-8. Article. |
1,638 |
Q3 |
|
2011 |
Clumeck, N.; Rieger, A.; Denes, B.; Schmidt, W.; Hill, A.; Van Delft,
Y.; Moecklinghoff, C.; Arribas, J. 96 week results from the MONET
trial: a randomized comparison of darunavir/ritonavir with versus without nucleoside analogues, for patients with HIV RNA < 50 copies/mL at baseline. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2011; 66(8): 1878-1885. Article. 5,068. D1 |
5,068 |
D1 |
|
2011 |
Imaz, A.; Llibre, J. M.; Mora, M.; Mateo, G.; Camacho, A.; Blanco,
J. R.; Curran, A.; Santos, J. R.; Caballero, E.; Bravo, I.; Gaya, F.;
Domingo, P.; Rivero, A.; Falco, V.; Clotet, B.; Ribera, E. Efficacy
and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2011; 66(2): 358-362. Article. |
5,068 |
D1 |
|
2011 |
Eron, J. J.; Rockstroh, J. K.; Reynes, J.; Andrade-Villanueva, J.; Ramalho-Madruga, J. V.; Bekker, L. G.; Young, B.; Katlama, C.; Gatell-Artigas, J. M.; Arribas, J. R.; Nelson, M.; Campbell, H.; Zhao, J.; Rodgers, A. J.; Rizk, M. L.; Wenning, L.; Miller, M. D.; Hazuda, D.; DiNubile, M. J.; Leavitt, R.; Isaacs, R.; Robertson, M. N.; Sklar, P.; Nguyen, B. Y. Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial. LANCET INFECTIOUS DISEASES. 2011; 11(12): 907-915. Article. |
17,391 |
D1 |
|
2011 |
Mathis, S.; Khanlari, B.; Pulido, F.; Schechter, M.; Negredo, E.; Nelson,
M.; Vernazza, P.; Cahn, P.; Meynard, J. L.; Arribas, J.; Bucher, H. C. Effectiveness of Protease Inhibitor Monotherapy versus Combination Antiretroviral Maintenance Therapy: A Meta-Analysis. PLOS ONE. 2011; 6(7): e22003. Article. |
4,092. |
Q1 |
|
2011 |
Panel de expertos de GESIDA y Plan Nacional sobre el Sida (Arribas López, J. R.) .National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update). ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2011; 29(3): e1-e103. Article. |
1,491 |
Q3 |
|
2011 |
Bernardino, J. I.; Mora, M.; Zamora, F. X.; Arribas, B.; Montes, M.
L.; Pascual-Pareja, F.; San José, B.; Peña, J. M.; Arribas, J. R. Hypertension and Isolated Office Hypertension in HIV-Infected Patients
Determined By Ambulatory Blood Pressure Monitoring: Prevalence and Risk Factors. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2011; 58(1): 54-59. Article. |
4,425 |
Q1 |
|
2011 |
Berenguer, J.; von Wichmann, M. A.; Quereda, C.; Miralles, P.; Mallolas, J.; López-Aldeguer, J.; Álvarez-Pellicer, J.; De Miguel, J.; Crespo, M.; Guardiola, J. M.; Téllez, M. J.; Galindo, M. J.; Arponen, S.; Barquilla, E.; Bellón, J. M.; González-García, J. Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2011; 66(12):2843-2849. Article. |
5,068. |
D1 |
|
2011 |
Sánchez-Conde, M.; Ramírez, M. L. M.; Cano, J. M. B.; Caminoa, A.; Rodríguez, F. A.; García, J. G.; Martín, P. M.; de la Serna, I. B.; de Quiros, J. C. L. B.; López, J. R. A.; Ochaita, J. C.; Pareja, J. F. P.; Álvarez, E.; Berenguer, J. B. Impact of liver steatosis on the correlation between liver stiffness and fibrosis measured by transient elastography in patients coinfected with human immunodeficiency virus and hepatitis C virus. JOURNAL OF VIRAL HEPATITIS. 2011; 18(7): E278-E283. Article. |
4,088 |
Q1 |
|
2011 |
López-Diéguez, M.; Montes, M. L.; Pascual-Pareja, J. F.; Quereda, C.; Von Wichmann, M. A.; Berenguer, J.; Tural, C.; Hernando, A.; González-García, J.; Serrano, L.; Arribas, J. R. The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patients. AIDS. 2011; 25(7): 899-904. Article. |
6,245 |
D1 |
|
2011 |
Tuma, P.; Pineda, J. A.; Labarga, P.; Vidal, F.; Rodríguez, C.; Poveda,
E.; Santos, J.; González-García, J.; Sobrino, P.; Tural, C.; Soriano,
V. HBV primary drug resistance in newly diagnosed HIV-HBVcoinfected
individuals in Spain. ANTIVIRAL THERAPY. 2011; 16(4): 585-589. Article. |
3,161 |
Q2 |
|
2011 |
Pérez-Valero, I.; Bayón, C.; Cambrón, I.; González, A.; Arribas, J. R.
Protease inhibitor monotherapy and the CNS: peace of mind? JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2011; 66(9): 1954-1962. Review. |
5,068 |
D1 |
|
2011 |
Merino, J. J.; Montes, M. L.; Blanco, A.; Bustos, M. J.; Oreja-Guevara,
C.; Bayón, C.; Cuadrado, A.; Lubrini, G.; Cambron, I.; Muñoz, A.; Cebolla, S.; Gutiérrez-Fernández, M.; Bernardino, J. I.; Arribas, J. R.;
Fiala, M. HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system. REVISTA DE NEUROLOGÍA. 2011; 52(2): 101-111. Article. |
0,652 |
Q4 |
|
2011 |
Briz, V.; Palladino, C.; Navarro, M. L.; de Ory, S. J.; González-Tome, M.I.; León, J. A.; Núñez-Cuadros, E.; de José, M. I.; Ramos, J. T.; Muñoz-Fernández, M. A. Etravirine-based highly active antiretroviral therapy in HIV-1-infected paediatric patients. HIV MEDICINE. 2011; 12(7):442-446. Article |
3,006 |
Q2 |
|
2011 |
Nso, A. P.; Larru, B.; Bellón, J. M.; Mellado, M. J.; Ramos, J. T.; González, M. I.; Navarro, M. L.; Muñoz-Fernández, M. A.; de José, M. I.HIV-Infected Adolescents: Relationship Between Atazanavir Plasma
Levels and Bilirubin Concentrations. JOURNAL OF ADOLESCENT
HEALTH. 2011; 48(1): 100-102. Article. |
3,334 |
D1 |
|
2011 |
Palladino, C.; Climent, F. J.; de José, M. I.; De Ory, S. J.; Bellón, J. M.;
Guillen, S.; Gurbindo, M. D.; González-Tome, I.; Mellado, M. J.; Pérez,
J. M.; Calvo, C.; Ramos, J. T.; Muñoz-Fernández, M. A. Causes of Death in Pediatric Patients Vertically Infected by the Human Immunodeficiency Virus Type 1 in Madrid, Spain, From 1982 to Mid-2009. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2011; 30(6): 495-500. Article. |
3,577 |
D1 |
|
2011 |
Viasus, D.; Paño-Pardo, J. R.; Cordero, E.; Campins, A.; López-Medrano, F.; Villoslada, A.; Farinas, M. C.; Moreno, A.; Rodríguez-Bano, J.; Oteo, J. A.; Martínez-Montauti, J.; Torre-Cisneros, J.; Segura, F.; Carratala, J. Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia. JOURNAL OF INFECTION. 2011; 62(3): 193-199. Article. |
4,126 |
Q1 |
|
2011 |
Paño-Pardo, J. R.; Martín-Quiros, A.; Romero-Gómez, M.; Maldonado,
J.; Martín-Vega, A.; Rico-Nieto, A.; Mora-Rillo, M.; Grill, F.; García-
Rodríguez, J.; Arribas, J. R.; Carratala, J.; Rodríguez-Bano, J. Perspectives from Spanish infectious diseases professionals on 2009 A (H1N1) influenza: the third half. CLINICAL MICROBIOLOGY AND INFECTION. 2011; 17(6): 845-850. Article. |
4,54 |
Q1 |
|
2011 |
Viasus, D.; Paño-Pardo, J. R.; Pachón, J.; Campins, A.; López-Medrano, F.;Villoslada, A.; Farinas, M. C.; Moreno, A.; Rodríguez-Bano, J.; Oteo, J. A.; Martínez-Montauti, J.; Torre-Cisneros, J.; Segura, F.; Gudiol, F.; Carratala, J. Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. CLINICAL MICROBIOLOGY AND INFECTION. 2011; 17(5): 738-746. Article. |
4,54 |
Q1 |
|
2011 |
Viasus, D.; Paño-Pardo, J. R.; Pachn, J.; Riera, M.; López-Medrano, F.;
Payeras, A.; Farinas, M. C.; Moreno, A.; Rodríguez-Bano, J.; Oteo, J. A.; Ortega, L.; Torre-Cisneros, J.; Segura, F.; Carratala, J. iming of Oseltamivir Administration and Outcomes in Hospitalized Adults With Pandemic 2009 Influenza A(H1N1) Virus Infection. CHEST. 2011; 140(4): 1025-1032. Article. |
5,25 |
D1 |
|
2011 |
Llorente, A.; Pérez-Valero, I.; García, E.; Heras, I.; Fraile, V.; García,
P.; López, J.; Salavert, M.; Bobillo, F. Mortality risk factors in patients
with zygomycosis: a retrospective and multicentre study of 25 cases.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2011; 29(4): 263-268. Article. |
1,491 |
Q3 |
|
2011 |
Paño-Pardo, J. R.; Padilla, B.; Romero-Gómez, M. P.; Moreno-Ramos,
F.; Rico-Nieto, A.; Mora-Rillo, M.; Horcajada, J. P.; Arribas, J. R.; Rodríguez-Bano, J. Monitoring activities and improvement in the use of
antibiotics in Spanish hospitals: results of a national survey. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2011; 29(1): 19-25. Article. |
1,491 |
Q3 |
|
2011 |
Paño-Pardo, J. R.; Martínez-Sánchez, N.; Martín-Quirós, A.; Romero-
Gómez, M. P.; Muñoz-Muñiz, M.; Sánchez-Pastor, M.; Ruiz, G.; San-José, B.; Prados, M. C.; Mora-Rillo, M.; Rico-Nieto, A.; Arribas, J. R. Influenza-like illness in pregnant women during summertime: clinical, epidemiological and microbiological features. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2011; 30(12): 1497-1502. Article. |
2,859 |
Q2 |
|
2011 |
Fernández, E. R.; Pardo, J. R. P.; Doyle, A.; Albendea, M. C.; de la Rua, A. R. Hemophagocytic syndrome associated NK/T nasal type lymphoma presenting as hypereosinophilic syndrome: A case report and literature review. LEUKEMIA RESEARCH. 2011; 35(7): E97-E99. Article. Letter. |
2,923 |
Q2 |
|
2011 |
Viasus, D.; Paño-Pardo, J. R.; Pachón, J.; Riera, M.; López-Medrano,
F.; Payeras, A.; Farinas, M. C.; Moreno, A.; Rodríguez-Bano, J.; Oteo,
J. A.; Martínez-Montauti, J.; Torre-Cisneros, J.; Segura, F.; Gudiol, F.;
Carratala, J. Pneumonia Complicating Pandemic (H1N1) 2009 Risk Factors, Clinical Features, and Outcomes. MEDICINE. 2011; 90(5): 328-336. Article. |
4,35 |
Q1 |
|
2010 |
Sánchez-Conde, M.; Montes-Ramírez, M. L.; Miralles, P.; Álvarez, J. M.; Bellón, J. M.; Ramírez, M.; Arribas, J. R.; Gutiérrez, I.; López, J. C.; Cosín, J.; Álvarez, E.; González, J; Berenguer, J. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers. JOURNAL OF VIRAL HEPATITIS. 2010; 17(4): 280-286. Article. |
3,502 |
Q2 |
|
2010 |
Rodríguez-Vila, B.; Gaya, F.; García-Vicente, F.; Gómez, E. J. Three-dimensional quantitative evaluation method of nonrigid registration algorithms for adaptive radiotherapy. MEDICAL PHYSICS. 2010; 37(3): 1137-1145. Article. |
3,07 |
Q1 |
|
2010 |
Miro, J. M.; Manzardo, C.; Pich, J.; Domingo, P.; Ferrer, E.; Arribas, J. R.; Ribera, E.; Arrizabalaga, J.; Lonca, M.; Cruceta, A.; de Lazzari, E.; Fuster, M.; Podzamczer, D.; Plana, M.; Gatell, J. M. Immune Reconstitution in Severely Immunosuppressed Antiretroviral-Naive HIV Type 1-Infected Patients Using a Nonnucleoside Reverse Transcriptase Inhibitor-Based or a Boosted Protease Inhibitor-Based Antiretroviral Regimen: Three-Year Results (The Advanz Trial): A Randomized, Controlled Trial. AIDS RESEARCH AND HUMAN RETROVIRUSES. 2010; 26(7): 747-757. Article. |
2,082 |
Q3 |
|
2010 |
González-García, J.; Cohen, D.; Johnson, M.; Sloan, L.; Fredrick, L.; Naylor, C.; da Silva, B.; Bernstein, B. Short Communication: Comparable Safety and Efficacy with Once-Daily Versus Twice-Daily Dosing of Lopinavir/Ritonavir Tablets with Emtricitabine plus Tenofovir DF in Antiretroviral-Naive, HIV Type 1-Infected Subjects: 96 Week Final Results of the Randomized Trial M05-730. AIDS RESEARCH AND HUMAN RETROVIRUSES. 2010; 26(8): 841-845. Article. |
2,082 |
Q3 |
|
2010 |
Rubio, R.; Serrano, O.; Carmena, J.; Asensi, V.; Echevarria, S.; Flores, J.; Ribera, E.; Zarraga, M.; Ocampo, A.; de la Fuente, B.; Sepulveda, M. A.; Marino, A. I.; Mínguez, C.; Vicent, R.; Carton, J. A.; Moyano, B.; Esteban, H.; Mahillo, B.; Serrano, L.; González-García, J. Effect of simplification from protease inhibitors to boosted atazanavir-based regimens in real-life conditions. HIV MEDICINE. 2010; 11(9): 545-553. Article. |
3,575 |
Q2 |
|
2010 |
Resino, S.; Palladino, C.; Lorente, R.; Micheloud, D.; Bellón, J. M.; Larru, B.; Gutiérrez, M. D. G.; de Jose, M. I.; Polo, R.; Muñoz-Fernández, M. A. Association between lipodystrophy and leptin in human immunodeficiency virus-1-infected children receiving lopinavir/ritonavir-based therapy. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2010; 29(8): 774-777. Article. |
3,064 |
Q1 |
|
2010 |
Guillén, S.; San Miguel, L. G.; Resino, S.; Bellón, J. M.; González, I.; de Ory, S. J.; Muñoz-Fernández, M. A.; Navarro, M. L.; Gurbindo, M. D.; de José, M. I.; Mellado, M. J.; Martín-Fontelos, P.; González-Tomé, M. I.; Martínez, J.; Beceiro, J.; Roa, M. A.; Ramos, J. T. Opportunistic infections and organ-specific diseases in HIV-1-infected children: a cohort study (1990-2006). HIV MEDICINE. 2010; 11(4): 245-252. Article. |
3,575 |
Q2 |
|
2010 |
Arribas, J. R.; Horban, A.; Gerstoft, J.; Fatkenheuer, G.; Nelson, M.; Clumeck, N.; Pulido, F.; Hill, A.; van Delft, Y.; Stark, T.; Moecklinghoff, C. The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml. AIDS. 2010; 24(2): 223-230. Article. |
6,348 |
Q1 |
|
2010 |
Palladino, C.; Briz, V.; Policarpo, S. N.; Silveira, L. F.; de Jose, M. I.; González-Tome, M. I.; Moreno, D.; Leal, J. A. L.; Mellado, M. J.; de Ory, S. J.; Ramos, J. T.; Muñoz-Fernández, M. A. Long-term efficacy and safety of fosamprenavir in human immunodeficiency virus-infected pediatric patients. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2010; 29(6): 563-566. Article. |
3,064 |
Q1 |
|
2010 |
Boer, K.; England, K.; Godfried, M. H.; Thorne, C.; Newell, M. L.; Mahdavi, S.; Giaquinto, C.; Rampon, O.; Mazza, A.; De Rossi, A.; Worner, I. G.; Mok, J.; de José, M. I.; Martínez, B. L.; Peña, J. M.; García, J. G.; López, J. R. A.; Rodríguez, M. C. G.; Asensi-Botet, F.; Otero, M. C.; Pérez-Tamarit, D.; Scherpbier, H. J.; Kreyenbroek, M.; Godfried, M. H.; Nellen, F. J. B.; Naver, L.; Bohlin, A. B.; Lindgren, S.; Kaldma, A.; Belfrage, E.; Levy, J.; Barlow, P.; Manigart, Y.; Hainaut, M.; Goetghebuer, T.; Brichard, B.; De Bruycker, J. J.; Thiry, N.; Waterloos, H.; Viscoli, C.; De María, A.; Bentivoglio, G.; Ferrero, S.; Gotta, C.; Mur, A.; Paya, A.; López-Vílchez, M. A.; Carreras, R.; Valerius, N. H.; Rosenfeldt, V.; Coll, O.; Suy, A.; Pérez, J. M.; Fortuny, C.; Boguna, J.; Savasi, V.; Fiore, S.; Crivelli, M.; Vigano, A.; Giacomet, V.; Cerini, C.; Raimondi, C.; Zuccotti, G.; Alberico, S.; Tropea, M.; Businelli, C.; Taylor, G. P.; Lyall, E. G. H.; Penn, Z.; Buffolano, W.; Tiseo, R.; Martinelli, P.; Sansone, M.; Maruotti, G.; Agangi, A.; Tibaldi, C.; Marini, S.; Masuelli, G.; Benedetto, C.; Niemiec, T.; Marczynska, M.; Dobosz, S.; Popielska, J.; Oldakowska, A.; Malyuta, R.; Semenenko, I.; Pilipenko, T. Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe. HIV MEDICINE. 2010; 11(6): 368-378. Article. |
3,575 |
Q2 |
|
2010 |
Palladino, C.; Briz, V.; González-Tome, M. I.; Leal, J. A. L.; Navarro, M. L.; de José, M. I.; Ramos, J. T.; Muñoz-Fernández, M. A. Short Communication: Evaluation of the Effect of Enfuvirtide in 11 HIV-1 Vertically Infected Pediatric Patients Outside Clinical Trials. AIDS RESEARCH AND HUMAN RETROVIRUSES. 2010; 26(3): 301-305. Article. |
2,082 |
Q3 |
|
2010 |
Rybniker, J.; Goede, V.; Mertens, J.; Ortmann, M.; Kulas, W.; Kochanek, M.; Benzing, T.; Arribas, J. R.; Fatkenheuer, G. Treatment of visceral leishmaniasis with intravenous pentamidine and oral fluconazole in an HIV-positive patient with chronic renal failure - a case report and brief review of the literatura. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2010; 14(6): E522-E525. Article. |
2,529 |
Q3 |
|
2010 |
Nso-Roca, A. P.; Larru, B.; Bellón, J. M.; Mellado, M. J.; Ramos, J. T.; González, M. I.; Navarro, M. L.; Muñoz-Fernández, M. A.; de Jose, M. I. Plasma antiretroviral levels in children with human immunodeficiency virus infection. Influence of sex and age. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2010; 28(5): 278-283. Article. |
1,656 |
Q3 |
|
2010 |
Nso, A. P.; Larru, B.; Bellón, J. M.; Mellado, M. J.; Ramos, J. T.; González, M. I.; Navarro, M. L.; Muñoz-Fernández, M. A.; de José, M. I. Comparison of levels of antiretroviral drugs with efficacy in children with HIV infection. INDIAN JOURNAL OF PEDIATRICS. 2010; 77(4): 397-402. Article. |
0,502 |
Q4 |
|
2010 |
Lifson, A. R.; Neuhaus, J.; Arribas, J. R.; van den Berg-Wolf, M.; Labriola, A. M.; Read, T. R. H. Smoking-Related Health Risks Among Persons With HIV in the Strategies for Management of Antiretroviral Therapy Clinical Trial. AMERICAN JOURNAL OF PUBLIC HEALTH. 2010; 100(10): 1896-1903. Article. |
3,85 |
Q1 |
|
2010 |
Stellbrink, H. J.; Orkin, C.; Arribas, J. R.; Compston, J.; Gerstoft, J.; Van Wijngaerden, E.; Lazzarin, A.; Rizzardini, G.; Sprenger, H. G.; Lambert, J.; Sture, G.; Leather, D.; Hughes, S.; Zucchi, P.; Pearce, H. Comparison of Changes in Bone Density and Turnover with Abacavir-Lamivudine versus Tenofovir-Emtricitabine in HIV-Infected Adults: 48-Week Results from the ASSERT Study. CLINICAL INFECTIOUS DISEASES. 2010; 51(8): 963-972. Article. |
8,16 |
Q1 |
|
2010 |
Pérez-Molina, J. A.; Rillo, M. M.; Suárez-Lozano, I.; Osorio, J. L. C.; Cobo, R. T.; González, P. R.; Clotet, E. P.; Jérez, A. H.; Pedrol, P. D.; Royuela, A.; Díaz, E. B.; Esteban, H.; González-García, J. Do HIV-Infected Immigrants Initiating HAART have Poorer Treatment-Related Outcomes than Autochthonous Patients in Spain? Results of the GESIDA 5808 Study. CURRENT HIV RESEARCH. 2010; 8(7): 521-530. Article. |
1,923 |
Q3 |
|
2010 |
Ibieta, M. F.; Cano, J. M. B.; Amador, J. T. R.; González-Tome, M. I.; Martín, S. G.; Gómez, M. N.; de José, M. I.; Beceiro, J.; Iglesias, E.; Prieto, L.; Santos, M. J.; Guardía, N. M.; Roa, M. A.; Regidor, J. In-utero Antiretroviral exposure and mitochondrial toxicity in a cohort of uninfected infants born to HIV-1-infected women. ANALES DE PEDIATRÍA. 2010; 73(4): 180-188. Article. |
0,57 |
Q4 |
|
2010 |
Estebánez-Muñoz, M.; Montes, M. L.; Ruiz-Seco, P.; Royo-Orejas, A.; González-García, J.; Arribas, J. R. Demyelinating disease in human immunodeficiency virus-infected patients without severe immunodepression. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2010; 28(9): 608-611. Article. |
1,656 |
Q3 |
|
2010 |
Winston, A.; Fatkenheuer, G.; Arribas, J.; Hill, A.; van Delft, Y.; Moecklinghoff, C. Neuropsychiatric adverse events with ritonavir-boosted-darunavir-monotherapy in HIV-infected individuals, a randomised prospective study. HIV CLINICAL TRIALS. 2010;11(3): 163-169. Article. |
1,835 |
Q3 |
|
2010 |
Fox, J.; Peters, B., Prakash, M.; Arribas, J.; Hill, A.; Moecklinghoff, C. Improvement in vitamin D deficiency following antiretroviral regime change: Results from the MONET trial. AIDS RESEARCH AND HUMAN RETROVIRUSES. 2010; 27(1): 29-34. Article. |
2,082 |
Q3 |
|
2010 |
Martínez, E.; Larrousse, M.; Podzamczer, D.; Pérez, I.;, Gutiérrez, F.; Loncá, M.; Barragán, P.; Deulofeu, R.; Casamitjana, R.; Mallolas, J.; Pich, J.; Gatell, J. M.; BICOMBO Study Team. (JR Arribas miembro del grupo). Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction. AIDS 2010; 28(3): F1-9. Article. |
6,348 |
Q1 |
|
2010 |
Llibre, J. M.; Antela, A.; Arribas, J. R.; Domingo, P.; Gatell, J. M.; López-Aldeguer, J.; Lozano, F.; Miralles, C.; Molto, J.; Moreno, S.; Ortega, E.; Riera, M.; Rivero, A.; Villalonga, C.; Clotet, B. Role of fixed-dose combinations of antiretrovirals in HIV-1 therapy. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2010; 28(9): 615-620. Review. |
1,656 |
Q3 |
|
2010 |
Moreno, S.; Aldeguer, J. L.; Arribas, J. R.; Domingo, P.; Iribarren, J. A.; Ribera, E.; Rivero, A.; Pulido, F. The future of antiretroviral therapy: challenges and needs. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2010; 65(5): 827-835. Review. |
4,659 |
Q1 |
|
2010 |
de la Serna, J. I. B.; Zamora, F. X.; Montes, M. L.; García-Puig, J.; Arribas, J. R. Hypertension, HIV infection, and highly active antiretroviric therapy. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2010; 28(1): 32-37. Review. |
1,656 |
Q3 |
|
2010 |
del Rosal, T.; Baquero-Artigao, F.; García-Miguel, M. J.; Méndez-Echevarría, A.; López, G.; Aracil, F. J.; de Jose, M. I.; del Castillo, F. Impact of Immigration on Pulmonary Tuberculosis in Spanish Children A Three-Decade Review. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2010; 29(7): 648-651. Review. |
3,064 |
Q1 |
|
2010 |
Rico, A.; Paño, J. R.; Cruz, A. Chronic osteomyelitis of the foot. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLINÍCA. 2010; 28(3): 200-202. Editorial Material. |
1,656 |
Q3 |
|
2010 |
Pareja, J. F.P.; García, J. G.; Montes, M. L.; Arribas, J. R. Liver steatosis and body fat in patients coinfected by human immunodeficiency and hepatitis C virus Reply. MEDICINA CLÍNICA. 2010; 134(4): 186-187. Letter. |
1,413 |
Q2 |
|
2010 |
Cordon, J. P.; Senent, S. G.; Franco, J. D. E.; Merino, L. A.; Arranz, E. M.; Herranz, M. J.; Martínez, L. C.; Villegas, M. P.; Bujalance, S. G.; Pardo, J. R. P.; Cabral, J. M. S. Can Whipple's disease be diagnosed through PCR techniques? GASTROENTEROLOGIA Y HEPATOLOGIA 2010; 33(5): 412-413. Letter. |
No tiene |
No tiene |
|
2010 |
Mora, M.; Rodríguez-Castellano, E.; Paño-Pardo, J. R.; González-García, J.; Navarro, C.; Figueira, J. C.; Arribas, J. R. Influenza A Pandemic (H1N1) 2009 Virus and HIV. EMERGING INFECTIOUS DISEASES. 2010; 16(7): 1175-1176. Letter. |
6,859 |
Q1 |
|
2010 |
Pérez-Valero, I.; Zamora, F. X.; Pulido, F.; Arribas, J. R. Incorrect attribution of cerebrospinal fluid HIV-1 virological escape and lymphocytic meningitis to lopinavir/ritonavir monotherapy. AIDS. 2010; 24(15): 2415-2416. Letter. |
6,348 |
Q1 |
|
2010 |
Arribas, J. R.; Pulido, F. Response to: "Assessment of Baseline HIV Viral Load as a Risk Factor for Loss of Virologic Suppression in Protease Inhibitor-Based Monotherapy Trials''. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2010; 53(5): 670-670. Letter. |
4,262 |
Q1 |
|
2010 |
Rico, A.; Paño, J. R.; Romero, M. P. Salmonella typhi bacteremia after biliary stenting. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2010; 28 (5): 237-329. Letter. |
1,656 |
Q3 |
|
2010 |
Paño-Pardo, J. R.; García, A.; Aracil, F.; Martínez, A. Community-associated methicillin-resistant Staphylococcus aureus disease in two members of a household in Spain. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2010; 28(7): 472-473. Letter. |
1,656 |
Q3 |
|
2010 |
Arribas, J. R.; Rivero, A.; Leal, M.; Sánchez-de la Rosa, R. Human immunodeficiency virus (HIV) type 1 with R5 tropism among HIV-1 antiretroviral-experienced patients in Spain. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2010; 28(8): 559-560. Letter. |
1,656 |
Q3 |
|
2010 |
de la Serna, J. I. B.; Montes, M. L.; Zamora, F. X. Outpatient blood pressure monitoring of the HIV patient reply. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2010; (9): 665-665. Letter. |
1,656 |
Q3 |
|
2009 |
Pascual-Pareja, JF; Caminoa, A; Larrauri, J; Gonzalez-Garcia, J; Montes, ML; Diez, J; Grande, M; Arribas, JR. HAART is associated with lower hepatic necroinflammatory activity in HIV-hepatitis C virus-coinfected patients with CD4 cell count of more than 350 cells/mu l at the time of liver biopsy. AIDS. 2009; 23(8): 971-975 |
4,909 |
Q1
|
|
2009 |
Pulido, F; Perez-Valero, I; Delgado, R; Arranz, A; Pasquau, J; Portilla, J; Rubio, R; Gonzalez-Garcia, J; Miralles, P; Perez-Elias, MJ; Ocampo, A; Hernando, A; Estrada, V; Clotet, B; Podzamczer, D; Arribas, JR. Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression. ANTIVIRAL THERAPY. 2009; 14(2): 195-201 |
4,322 |
Q1
|
|
2009 |
Cachafeiro, SP; Del Amo, J; Iribarren, JA; Lleti, MS; Gutierrez, F; Moreno, A; Labarga, P; Pineda, JA; Vidal, F; Berenguer, J; Moreno, S. Decrease in Serial Prevalence of Coinfection with Hepatitis C Virus among HIV-Infected Patients in Spain, 1997-2006. CLINICAL INFECTIOUS DISEASES. 2009; 48(10): 1467-1470 |
8,195 |
Q1
|
|
2009 |
Perez-Elias, MJ; Miguel, LGS; Garcia, JG; Ramirez, MLM; Muriel, A; Machin-Lazaro, JM; Martinez-Baltanas, A; Zamora, F; Moreno, A; Martin-Davila, P; Quereda, C; Gomez-Mampaso, E; Moreno, S. Tuberculosis Complicating Hepatitis C Treatment in HIV-Infected Patients. CLINICAL INFECTIOUS DISEASES. 2009; 48(8): E82-E85 |
8,195 |
Q1
|
|
2009 |
Arribas,J. R.. Drugs in traditional drug classes (nucleoside reverse transcriptase inhibitor/nonnucleoside reverse transcriptase inhibitor/protease inhibitors) with activity against drug-resistant virus (tipranavir, darunavir, etravirine). CURRENT OPINION IN HIV AND AIDS. 2009; 4(6): 507-512 |
No tiene |
No tiene
|
|
2009 |
Rico, A; Pano-Pardo, JR; Montes, ML; Mingorance, J. An HIV-positive homosexual man with fever and a skin lesion. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2009; 27(7): 419-421 |
1,393 |
Q4
|
|
2009 |
Montes, ML; Fraile, JM; Gonzalez, JJ; Arribas, JR. Chorea during treatment with pegylated interferon and ribavirin in HIV-HCV coinfected patient. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2009; 27(1): 60-61 |
1,393 |
Q4
|
|
2009 |
Bernardino de la Serna,J. I.;Arribas Lopez,J. R.. Controversies and future of the approach to cardiovascular disease in HIV patients. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2009; 27 Suppl 1: 48-53 |
1,393 |
Q4
|
|
2009 |
Panel de expertos de Gesida y Plan Nacional sobre el Sida. Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009). ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2009; 27(4): 222-235 |
1,393 |
Q4
|
|
2009 |
Berenguer, J; Alvarez-Pellicer, J; Martin, PM; Lopez-Aldeguer, J; Von-Wichmann, MA; Quereda, C; Mallolas, J; Sanz, J; Tural, C; Bellon, JM; Gonzalez-Garcia, J. Sustained Virological Response to Interferon Plus Ribavirin Reduces Liver-Related Complications and Mortality in Patients Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus. HEPATOLOGY. 2009; 50(2): 407-413 |
10,840 |
Q1
|
|
2009 |
Pozniak, A; Gupta, RK; Pillay, D; Arribas, J; Hill, A. Causes and Consequences of Incomplete HIV RNA Suppression in Clinical Trials. HIV CLINICAL TRIALS. 2009; 10(5): 289-298 |
1,626 |
Q3
|
|
2009 |
Patel, D; Thorne, C; Newell, ML; Cortina-Borja, M; Giaquinto, C; Rampon, O; D'Elia, R; De Rossi, A; Grosch-Worner, I; Mok, J; de Jose, MI; Martinez, BL; Pena, JM; Garcia, JG; Lopez, JRA; Garcia-Rodriguez, J; Asensi-Botet, F; Otero, MC; Perez-Tamarit, D; S. Levels and patterns of HIV RNA viral load in untreated pregnant women. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2009; 13(2): 266-273 |
2,167 |
Q3
|
|
2009 |
Pano-Pardo,J. R.;Alcaide,M. L.;Abbo,L.;Dickinson,G.. Primary HIV infection with multisystemic presentation. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2009; 13(4): e177-80 |
2,167 |
Q3
|
|
2009 |
Martinez, E; Arranz, JA; Podzamczer, D; Lonca, M; Sanz, J; Barragan, P; Ribera, E; Knobel, H; Roca, V; Gutierrez, F; Blanco, JL; Mallolas, J; Llibre, JM; Clotet, B; Dalmau, D; Segura, F; Arribas, JR; Cosin, J; Barrufet, P; Casas, E; Ferrer, E; Curran, A;. A Simplification Trial Switching From Nucleoside Reverse Transcriptase Inhibitors to Once-Daily Fixed-Dose Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1-Infected Patients With Virological Suppression. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2009; 51(3): 290-297 |
4,207 |
Q1
|
|
2009 |
Domingo, P; Suarez-Lozano, I; Torres, F; Pomar, V; Ribera, E; Galindo, MJ; Cosin, J; Garcia-Alcalde, ML; Vidal, F; Lopez-Aldeguer, J; Roca, B; Gonzalez, J; Lozano, F; Garrido, M. Bacterial Meningitis in HIV-1-infected Patients in the Era of Highly Active Antiretroviral Therapy. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2009; 51(5): 582-587 |
4,207 |
Q1
|
|
2009 |
Sension, M; Neto, JLD; Grinsztejn, B; Molina, JM; Zavala, I; Gonzalez-Garcia, J; Donnelly, A; Phiri, P; Ledesma, E; McGrath, D. Improvement in Lipid Profiles in Antiretroviral-Experienced HIV-Positive Patients With Hyperlipidemia After a Switch to Unboosted Atazanavir. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2009; 51(2): 153-162 |
4,207 |
Q1
|
|
2009 |
Arribas, JR; Delgado, R; Arranz, A; Munoz, R; Portilla, J; Pasquau, J; Perez-Elias, MJ; Iribarren, JA; Rubio, R; Ocampo, A; Sanchez-Conde, M; Knobel, H; Arazo, P; Sanz, J; Lopez-Aldeguer, J; Montes, ML; Pulido, F. Lopinavir-Ritonavir Monotherapy Versus Lopinavir-Ritonavir and 2 Nucleosides for Maintenance Therapy of HIV: 96-Week Analysis. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2009; 51(2): 147-152 |
4,207 |
Q1
|
|
2009 |
Garriga, C; Perez-Elias, MJ; Delgado, R; Ruiz, L; Perez-Alvarez, L; Pumarola, T; Lopez-Lirola, A; Gonzalez-Garcia, J; Menendez-Arias, L. HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2009; 64(2): 251-258 |
4,352 |
Q1
|
|
2009 |
Berenguer, J; Gonzalez-Garcia, J; Lopez-Aldeguer, J; Von-Wichmann, MA; Quereda, C; Hernando, A; Sanz, J; Tural, C; Ortega, E; Mallolas, J; Santos, I; Miralles, P; Montes, ML; Bellon, JM; Esteban, H. Pegylated interferon alpha 2a plus ribavirin versus pegylated interferon alpha 2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2009; 63(6): 1256-1263 |
4,352 |
Q1
|
|
2009 |
Pareja, JFP; Montes, ML; Gonzalez-Garcia, J; Arribas, JR. Spontaneous Viral Clearance, Viral Load, and Genotype Distribution of Hepatitis C Virus (HCV) in European HIV-Infected Patients with Anti-HCV Antibodies. JOURNAL OF INFECTIOUS DISEASES. 2009; 199(10): 1556-1557 |
5,865 |
Q1
|
|
2009 |
Pareja, JFP; Camino, A; Larrauri, J; Lopez-Dieguez, M; Montes, ML; Gonzalez-Garcia, J; Pena, JM; Diez, J; Arribas, JR. Factors associated with hepatic steatosis in human immunodeficiency virus and hepatits C virus coinfected patients. MEDICINA CLINICA. 2009; 132(6): 208-213 |
1,231 |
Q3
|
|
2009 |
Arribas, JR; Mora, M; Pascual-Pareja, JF. Early versus Deferred Antiretroviral Therapy for HIV. NEW ENGLAND JOURNAL OF MEDICINE. 2009; 361(8): 823-823 |
47,050 |
Q1
|
|
2009 |
Abrams, D; Levy, Y; Losso, MH; Babilker, A; Collins, G; Cooper, DA; Darbyshire, J; Emery, S; Fox, L; Gordin, F; Lane, HC; Lundgren, JD; Mitsuyasu, R; Neaton, JD; Phillips, A; Routy, JP; Tambussi, G; Wentworth, D. Interleukin-2 Therapy in Patients with HIV Infection. NEW ENGLAND JOURNAL OF MEDICINE. 2009; 361(16): 1548-1559 |
47,050 |
Q1
|
|
|
|
|